US20030013174A1 - Genes for lysine biosynthetic system derived from thermophilic bacteria - Google Patents
Genes for lysine biosynthetic system derived from thermophilic bacteria Download PDFInfo
- Publication number
- US20030013174A1 US20030013174A1 US10/214,556 US21455602A US2003013174A1 US 20030013174 A1 US20030013174 A1 US 20030013174A1 US 21455602 A US21455602 A US 21455602A US 2003013174 A1 US2003013174 A1 US 2003013174A1
- Authority
- US
- United States
- Prior art keywords
- dna
- protein
- val
- gly
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 147
- 239000004472 Lysine Substances 0.000 title claims description 25
- 241000894006 Bacteria Species 0.000 title description 9
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 title description 5
- 230000001851 biosynthetic effect Effects 0.000 title 1
- 108091000044 4-hydroxy-tetrahydrodipicolinate synthase Proteins 0.000 claims abstract description 11
- 108010014468 Dihydrodipicolinate Reductase Proteins 0.000 claims abstract description 11
- 150000001413 amino acids Chemical group 0.000 claims description 51
- 239000002773 nucleotide Substances 0.000 claims description 49
- 125000003729 nucleotide group Chemical group 0.000 claims description 49
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 48
- 235000018102 proteins Nutrition 0.000 claims description 42
- 102000004169 proteins and genes Human genes 0.000 claims description 42
- 230000000694 effects Effects 0.000 claims description 28
- 235000019766 L-Lysine Nutrition 0.000 claims description 24
- 235000001014 amino acid Nutrition 0.000 claims description 20
- 244000005700 microbiome Species 0.000 claims description 18
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 12
- 238000007792 addition Methods 0.000 claims description 12
- 238000012217 deletion Methods 0.000 claims description 12
- 230000037430 deletion Effects 0.000 claims description 12
- 238000003780 insertion Methods 0.000 claims description 12
- 230000037431 insertion Effects 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 238000006467 substitution reaction Methods 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 5
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims description 3
- 108020004414 DNA Proteins 0.000 abstract description 64
- 241000193398 Bacillus methanolicus Species 0.000 abstract description 27
- 230000002950 deficient Effects 0.000 abstract description 13
- 108020004511 Recombinant DNA Proteins 0.000 abstract description 11
- 210000000349 chromosome Anatomy 0.000 abstract description 11
- 241000588722 Escherichia Species 0.000 abstract description 10
- 239000002609 medium Substances 0.000 description 53
- 238000000034 method Methods 0.000 description 33
- 239000000243 solution Substances 0.000 description 29
- 241000588724 Escherichia coli Species 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 239000013598 vector Substances 0.000 description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 241000282326 Felis catus Species 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- 229920001817 Agar Polymers 0.000 description 9
- 241000193830 Bacillus <bacterium> Species 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 239000008272 agar Substances 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 8
- 235000014469 Bacillus subtilis Nutrition 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- 241000841328 Bacillus methanolicus PB1 Species 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 108010089804 glycyl-threonine Proteins 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 5
- 244000063299 Bacillus subtilis Species 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 5
- 241000186216 Corynebacterium Species 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 5
- 229960005091 chloramphenicol Drugs 0.000 description 5
- 238000004520 electroporation Methods 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- GMKMEZVLHJARHF-UHFFFAOYSA-N 2,6-diaminopimelic acid Chemical compound OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 4
- FJVAQLJNTSUQPY-CIUDSAMLSA-N Ala-Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN FJVAQLJNTSUQPY-CIUDSAMLSA-N 0.000 description 4
- NMRHDSAOIURTNT-RWMBFGLXSA-N Arg-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N NMRHDSAOIURTNT-RWMBFGLXSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000186226 Corynebacterium glutamicum Species 0.000 description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- UQCNIMDPYICBTR-KYNKHSRBSA-N Thr-Thr-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O UQCNIMDPYICBTR-KYNKHSRBSA-N 0.000 description 4
- AEFJNECXZCODJM-UWVGGRQHSA-N Val-Val-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)NCC([O-])=O AEFJNECXZCODJM-UWVGGRQHSA-N 0.000 description 4
- 235000003704 aspartic acid Nutrition 0.000 description 4
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 4
- 108010034529 leucyl-lysine Proteins 0.000 description 4
- 108010054155 lysyllysine Proteins 0.000 description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- UWOCFOFVIBZJGH-UHFFFAOYSA-N 2,3-dihydrodipicolinic acid Chemical compound OC(=O)C1CC=CC(C(O)=O)=N1 UWOCFOFVIBZJGH-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- 241000186031 Corynebacteriaceae Species 0.000 description 3
- 241000880493 Leptailurus serval Species 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- CWFMWBHMIMNZLN-NAKRPEOUSA-N (2s)-1-[(2s)-2-[[(2s,3s)-2-amino-3-methylpentanoyl]amino]propanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CWFMWBHMIMNZLN-NAKRPEOUSA-N 0.000 description 2
- AUXMWYRZQPIXCC-KNIFDHDWSA-N (2s)-2-amino-4-methylpentanoic acid;(2s)-2-aminopropanoic acid Chemical compound C[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O AUXMWYRZQPIXCC-KNIFDHDWSA-N 0.000 description 2
- JDIIGWSSTNUWGK-UHFFFAOYSA-N 1h-imidazol-3-ium;chloride Chemical compound [Cl-].[NH2+]1C=CN=C1 JDIIGWSSTNUWGK-UHFFFAOYSA-N 0.000 description 2
- GORKKVHIBWAQHM-GCJQMDKQSA-N Ala-Asn-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GORKKVHIBWAQHM-GCJQMDKQSA-N 0.000 description 2
- PUBLUECXJRHTBK-ACZMJKKPSA-N Ala-Glu-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O PUBLUECXJRHTBK-ACZMJKKPSA-N 0.000 description 2
- OBVSBEYOMDWLRJ-BFHQHQDPSA-N Ala-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N OBVSBEYOMDWLRJ-BFHQHQDPSA-N 0.000 description 2
- LTSBJNNXPBBNDT-HGNGGELXSA-N Ala-His-Gln Chemical compound N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(=O)O LTSBJNNXPBBNDT-HGNGGELXSA-N 0.000 description 2
- SUMYEVXWCAYLLJ-GUBZILKMSA-N Ala-Leu-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O SUMYEVXWCAYLLJ-GUBZILKMSA-N 0.000 description 2
- VCSABYLVNWQYQE-SRVKXCTJSA-N Ala-Lys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O VCSABYLVNWQYQE-SRVKXCTJSA-N 0.000 description 2
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 2
- DRARURMRLANNLS-GUBZILKMSA-N Ala-Met-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O DRARURMRLANNLS-GUBZILKMSA-N 0.000 description 2
- VQAVBBCZFQAAED-FXQIFTODSA-N Ala-Pro-Asn Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)O)N VQAVBBCZFQAAED-FXQIFTODSA-N 0.000 description 2
- YHBDGLZYNIARKJ-GUBZILKMSA-N Ala-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N YHBDGLZYNIARKJ-GUBZILKMSA-N 0.000 description 2
- YJHKTAMKPGFJCT-NRPADANISA-N Ala-Val-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O YJHKTAMKPGFJCT-NRPADANISA-N 0.000 description 2
- VHAQSYHSDKERBS-XPUUQOCRSA-N Ala-Val-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O VHAQSYHSDKERBS-XPUUQOCRSA-N 0.000 description 2
- XCIGOVDXZULBBV-DCAQKATOSA-N Ala-Val-Lys Chemical compound CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(O)=O XCIGOVDXZULBBV-DCAQKATOSA-N 0.000 description 2
- GIVATXIGCXFQQA-FXQIFTODSA-N Arg-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N GIVATXIGCXFQQA-FXQIFTODSA-N 0.000 description 2
- HPKSHFSEXICTLI-CIUDSAMLSA-N Arg-Glu-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O HPKSHFSEXICTLI-CIUDSAMLSA-N 0.000 description 2
- AQPVUEJJARLJHB-BQBZGAKWSA-N Arg-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N AQPVUEJJARLJHB-BQBZGAKWSA-N 0.000 description 2
- BMNVSPMWMICFRV-DCAQKATOSA-N Arg-His-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CN=CN1 BMNVSPMWMICFRV-DCAQKATOSA-N 0.000 description 2
- VVJTWSRNMJNDPN-IUCAKERBSA-N Arg-Met-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O VVJTWSRNMJNDPN-IUCAKERBSA-N 0.000 description 2
- NNMUHYLAYUSTTN-FXQIFTODSA-N Asn-Gln-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O NNMUHYLAYUSTTN-FXQIFTODSA-N 0.000 description 2
- IICZCLFBILYRCU-WHFBIAKZSA-N Asn-Gly-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IICZCLFBILYRCU-WHFBIAKZSA-N 0.000 description 2
- FTCGGKNCJZOPNB-WHFBIAKZSA-N Asn-Gly-Ser Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FTCGGKNCJZOPNB-WHFBIAKZSA-N 0.000 description 2
- YYSYDIYQTUPNQQ-SXTJYALSSA-N Asn-Ile-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YYSYDIYQTUPNQQ-SXTJYALSSA-N 0.000 description 2
- NYGILGUOUOXGMJ-YUMQZZPRSA-N Asn-Lys-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O NYGILGUOUOXGMJ-YUMQZZPRSA-N 0.000 description 2
- VHQSGALUSWIYOD-QXEWZRGKSA-N Asn-Pro-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O VHQSGALUSWIYOD-QXEWZRGKSA-N 0.000 description 2
- XBQSLMACWDXWLJ-GHCJXIJMSA-N Asp-Ala-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XBQSLMACWDXWLJ-GHCJXIJMSA-N 0.000 description 2
- XPGVTUBABLRGHY-BIIVOSGPSA-N Asp-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N XPGVTUBABLRGHY-BIIVOSGPSA-N 0.000 description 2
- VPSHHQXIWLGVDD-ZLUOBGJFSA-N Asp-Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VPSHHQXIWLGVDD-ZLUOBGJFSA-N 0.000 description 2
- FANQWNCPNFEPGZ-WHFBIAKZSA-N Asp-Asp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FANQWNCPNFEPGZ-WHFBIAKZSA-N 0.000 description 2
- HRGGPWBIMIQANI-GUBZILKMSA-N Asp-Gln-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HRGGPWBIMIQANI-GUBZILKMSA-N 0.000 description 2
- SNAWMGHSCHKSDK-GUBZILKMSA-N Asp-Gln-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N SNAWMGHSCHKSDK-GUBZILKMSA-N 0.000 description 2
- KQBVNNAPIURMPD-PEFMBERDSA-N Asp-Ile-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O KQBVNNAPIURMPD-PEFMBERDSA-N 0.000 description 2
- ORRJQLIATJDMQM-HJGDQZAQSA-N Asp-Leu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O ORRJQLIATJDMQM-HJGDQZAQSA-N 0.000 description 2
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 2
- KNDCWFXCFKSEBM-AVGNSLFASA-N Asp-Tyr-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O KNDCWFXCFKSEBM-AVGNSLFASA-N 0.000 description 2
- 102100021277 Beta-secretase 2 Human genes 0.000 description 2
- 101710150190 Beta-secretase 2 Proteins 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- CUXIOFHFFXNUGG-HTFCKZLJSA-N Cys-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CS)N CUXIOFHFFXNUGG-HTFCKZLJSA-N 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- LVSYIKGMLRHKME-IUCAKERBSA-N Gln-Gly-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)N LVSYIKGMLRHKME-IUCAKERBSA-N 0.000 description 2
- LKVCNGLNTAPMSZ-JYJNAYRXSA-N Gln-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCC(=O)N)N LKVCNGLNTAPMSZ-JYJNAYRXSA-N 0.000 description 2
- GJLXZITZLUUXMJ-NHCYSSNCSA-N Gln-Val-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCC(=O)N)N GJLXZITZLUUXMJ-NHCYSSNCSA-N 0.000 description 2
- UTKUTMJSWKKHEM-WDSKDSINSA-N Glu-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O UTKUTMJSWKKHEM-WDSKDSINSA-N 0.000 description 2
- CVPXINNKRTZBMO-CIUDSAMLSA-N Glu-Arg-Asn Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)CN=C(N)N CVPXINNKRTZBMO-CIUDSAMLSA-N 0.000 description 2
- LGYZYFFDELZWRS-DCAQKATOSA-N Glu-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O LGYZYFFDELZWRS-DCAQKATOSA-N 0.000 description 2
- YVYVMJNUENBOOL-KBIXCLLPSA-N Glu-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N YVYVMJNUENBOOL-KBIXCLLPSA-N 0.000 description 2
- XNOWYPDMSLSRKP-GUBZILKMSA-N Glu-Met-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(O)=O XNOWYPDMSLSRKP-GUBZILKMSA-N 0.000 description 2
- LKOAAMXDJGEYMS-ZPFDUUQYSA-N Glu-Met-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LKOAAMXDJGEYMS-ZPFDUUQYSA-N 0.000 description 2
- BPLNJYHNAJVLRT-ACZMJKKPSA-N Glu-Ser-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O BPLNJYHNAJVLRT-ACZMJKKPSA-N 0.000 description 2
- DLISPGXMKZTWQG-IFFSRLJSSA-N Glu-Thr-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O DLISPGXMKZTWQG-IFFSRLJSSA-N 0.000 description 2
- JVWPPCWUDRJGAE-YUMQZZPRSA-N Gly-Asn-Leu Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JVWPPCWUDRJGAE-YUMQZZPRSA-N 0.000 description 2
- NPSWCZIRBAYNSB-JHEQGTHGSA-N Gly-Gln-Thr Chemical compound [H]NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NPSWCZIRBAYNSB-JHEQGTHGSA-N 0.000 description 2
- ITZOBNKQDZEOCE-NHCYSSNCSA-N Gly-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CN ITZOBNKQDZEOCE-NHCYSSNCSA-N 0.000 description 2
- ULZCYBYDTUMHNF-IUCAKERBSA-N Gly-Leu-Glu Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ULZCYBYDTUMHNF-IUCAKERBSA-N 0.000 description 2
- LRQXRHGQEVWGPV-NHCYSSNCSA-N Gly-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN LRQXRHGQEVWGPV-NHCYSSNCSA-N 0.000 description 2
- TVUWMSBGMVAHSJ-KBPBESRZSA-N Gly-Leu-Phe Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 TVUWMSBGMVAHSJ-KBPBESRZSA-N 0.000 description 2
- AFWYPMDMDYCKMD-KBPBESRZSA-N Gly-Leu-Tyr Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 AFWYPMDMDYCKMD-KBPBESRZSA-N 0.000 description 2
- BXICSAQLIHFDDL-YUMQZZPRSA-N Gly-Lys-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BXICSAQLIHFDDL-YUMQZZPRSA-N 0.000 description 2
- RVGMVLVBDRQVKB-UWVGGRQHSA-N Gly-Met-His Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN RVGMVLVBDRQVKB-UWVGGRQHSA-N 0.000 description 2
- GAFKBWKVXNERFA-QWRGUYRKSA-N Gly-Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 GAFKBWKVXNERFA-QWRGUYRKSA-N 0.000 description 2
- YYXJFBMCOUSYSF-RYUDHWBXSA-N Gly-Phe-Gln Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O YYXJFBMCOUSYSF-RYUDHWBXSA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- VTZYMXGGXOFBMX-DJFWLOJKSA-N His-Ile-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O VTZYMXGGXOFBMX-DJFWLOJKSA-N 0.000 description 2
- WECYRWOMWSCWNX-XUXIUFHCSA-N Ile-Arg-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(O)=O WECYRWOMWSCWNX-XUXIUFHCSA-N 0.000 description 2
- DFJJAVZIHDFOGQ-MNXVOIDGSA-N Ile-Glu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DFJJAVZIHDFOGQ-MNXVOIDGSA-N 0.000 description 2
- XLCZWMJPVGRWHJ-KQXIARHKSA-N Ile-Glu-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N XLCZWMJPVGRWHJ-KQXIARHKSA-N 0.000 description 2
- NZOCIWKZUVUNDW-ZKWXMUAHSA-N Ile-Gly-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O NZOCIWKZUVUNDW-ZKWXMUAHSA-N 0.000 description 2
- SLQVFYWBGNNOTK-BYULHYEWSA-N Ile-Gly-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N SLQVFYWBGNNOTK-BYULHYEWSA-N 0.000 description 2
- CDGLBYSAZFIIJO-RCOVLWMOSA-N Ile-Gly-Gly Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O CDGLBYSAZFIIJO-RCOVLWMOSA-N 0.000 description 2
- HYLIOBDWPQNLKI-HVTMNAMFSA-N Ile-His-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N HYLIOBDWPQNLKI-HVTMNAMFSA-N 0.000 description 2
- KEKTTYCXKGBAAL-VGDYDELISA-N Ile-His-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)O)N KEKTTYCXKGBAAL-VGDYDELISA-N 0.000 description 2
- SJLVSMMIFYTSGY-GRLWGSQLSA-N Ile-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SJLVSMMIFYTSGY-GRLWGSQLSA-N 0.000 description 2
- RQJUKVXWAKJDBW-SVSWQMSJSA-N Ile-Ser-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N RQJUKVXWAKJDBW-SVSWQMSJSA-N 0.000 description 2
- HXIDVIFHRYRXLZ-NAKRPEOUSA-N Ile-Ser-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)O)N HXIDVIFHRYRXLZ-NAKRPEOUSA-N 0.000 description 2
- 108010065920 Insulin Lispro Proteins 0.000 description 2
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 2
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 2
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 2
- GHSJKUNUIHUPDF-BYPYZUCNSA-N L-thialysine Chemical compound NCCSC[C@H](N)C(O)=O GHSJKUNUIHUPDF-BYPYZUCNSA-N 0.000 description 2
- ZURHXHNAEJJRNU-CIUDSAMLSA-N Leu-Asp-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZURHXHNAEJJRNU-CIUDSAMLSA-N 0.000 description 2
- AOFYPTOHESIBFZ-KKUMJFAQSA-N Leu-His-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O AOFYPTOHESIBFZ-KKUMJFAQSA-N 0.000 description 2
- USLNHQZCDQJBOV-ZPFDUUQYSA-N Leu-Ile-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O USLNHQZCDQJBOV-ZPFDUUQYSA-N 0.000 description 2
- IAJFFZORSWOZPQ-SRVKXCTJSA-N Leu-Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IAJFFZORSWOZPQ-SRVKXCTJSA-N 0.000 description 2
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 2
- WXZOHBVPVKABQN-DCAQKATOSA-N Leu-Met-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)O)N WXZOHBVPVKABQN-DCAQKATOSA-N 0.000 description 2
- KQFZKDITNUEVFJ-JYJNAYRXSA-N Leu-Phe-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)CC1=CC=CC=C1 KQFZKDITNUEVFJ-JYJNAYRXSA-N 0.000 description 2
- LJBVRCDPWOJOEK-PPCPHDFISA-N Leu-Thr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LJBVRCDPWOJOEK-PPCPHDFISA-N 0.000 description 2
- XZNJZXJZBMBGGS-NHCYSSNCSA-N Leu-Val-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O XZNJZXJZBMBGGS-NHCYSSNCSA-N 0.000 description 2
- PNPYKQFJGRFYJE-GUBZILKMSA-N Lys-Ala-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNPYKQFJGRFYJE-GUBZILKMSA-N 0.000 description 2
- NFLFJGGKOHYZJF-BJDJZHNGSA-N Lys-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN NFLFJGGKOHYZJF-BJDJZHNGSA-N 0.000 description 2
- NTSPQIONFJUMJV-AVGNSLFASA-N Lys-Arg-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O NTSPQIONFJUMJV-AVGNSLFASA-N 0.000 description 2
- 108010062166 Lys-Asn-Asp Proteins 0.000 description 2
- BYPMOIFBQPEWOH-CIUDSAMLSA-N Lys-Asn-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N BYPMOIFBQPEWOH-CIUDSAMLSA-N 0.000 description 2
- PBIPLDMFHAICIP-DCAQKATOSA-N Lys-Glu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PBIPLDMFHAICIP-DCAQKATOSA-N 0.000 description 2
- LPAJOCKCPRZEAG-MNXVOIDGSA-N Lys-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCCN LPAJOCKCPRZEAG-MNXVOIDGSA-N 0.000 description 2
- WGLAORUKDGRINI-WDCWCFNPSA-N Lys-Glu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGLAORUKDGRINI-WDCWCFNPSA-N 0.000 description 2
- IUWMQCZOTYRXPL-ZPFDUUQYSA-N Lys-Ile-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O IUWMQCZOTYRXPL-ZPFDUUQYSA-N 0.000 description 2
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 2
- VMTYLUGCXIEDMV-QWRGUYRKSA-N Lys-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN VMTYLUGCXIEDMV-QWRGUYRKSA-N 0.000 description 2
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- CHQWUYSNAOABIP-ZPFDUUQYSA-N Met-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)N CHQWUYSNAOABIP-ZPFDUUQYSA-N 0.000 description 2
- BMHIFARYXOJDLD-WPRPVWTQSA-N Met-Gly-Val Chemical compound [H]N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O BMHIFARYXOJDLD-WPRPVWTQSA-N 0.000 description 2
- FZUNSVYYPYJYAP-NAKRPEOUSA-N Met-Ile-Ala Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O FZUNSVYYPYJYAP-NAKRPEOUSA-N 0.000 description 2
- ZRACLHJYVRBJFC-ULQDDVLXSA-N Met-Lys-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZRACLHJYVRBJFC-ULQDDVLXSA-N 0.000 description 2
- LXCSZPUQKMTXNW-BQBZGAKWSA-N Met-Ser-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O LXCSZPUQKMTXNW-BQBZGAKWSA-N 0.000 description 2
- IHRFZLQEQVHXFA-RHYQMDGZSA-N Met-Thr-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCCN IHRFZLQEQVHXFA-RHYQMDGZSA-N 0.000 description 2
- LBSWWNKMVPAXOI-GUBZILKMSA-N Met-Val-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O LBSWWNKMVPAXOI-GUBZILKMSA-N 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 2
- ULECEJGNDHWSKD-QEJZJMRPSA-N Phe-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 ULECEJGNDHWSKD-QEJZJMRPSA-N 0.000 description 2
- SXJGROGVINAYSH-AVGNSLFASA-N Phe-Gln-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N SXJGROGVINAYSH-AVGNSLFASA-N 0.000 description 2
- KJJROSNFBRWPHS-JYJNAYRXSA-N Phe-Glu-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O KJJROSNFBRWPHS-JYJNAYRXSA-N 0.000 description 2
- RFEXGCASCQGGHZ-STQMWFEESA-N Phe-Gly-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O RFEXGCASCQGGHZ-STQMWFEESA-N 0.000 description 2
- BIYWZVCPZIFGPY-QWRGUYRKSA-N Phe-Gly-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CO)C(O)=O BIYWZVCPZIFGPY-QWRGUYRKSA-N 0.000 description 2
- YTILBRIUASDGBL-BZSNNMDCSA-N Phe-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 YTILBRIUASDGBL-BZSNNMDCSA-N 0.000 description 2
- PTDAGKJHZBGDKD-OEAJRASXSA-N Phe-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N)O PTDAGKJHZBGDKD-OEAJRASXSA-N 0.000 description 2
- GAMLAXHLYGLQBJ-UFYCRDLUSA-N Phe-Val-Tyr Chemical compound N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC1=CC=C(C=C1)O)C(C)C)CC1=CC=CC=C1 GAMLAXHLYGLQBJ-UFYCRDLUSA-N 0.000 description 2
- BNBBNGZZKQUWCD-IUCAKERBSA-N Pro-Arg-Gly Chemical compound NC(N)=NCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H]1CCCN1 BNBBNGZZKQUWCD-IUCAKERBSA-N 0.000 description 2
- OBVCYFIHIIYIQF-CIUDSAMLSA-N Pro-Asn-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O OBVCYFIHIIYIQF-CIUDSAMLSA-N 0.000 description 2
- XWYXZPHPYKRYPA-GMOBBJLQSA-N Pro-Asn-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XWYXZPHPYKRYPA-GMOBBJLQSA-N 0.000 description 2
- DMKWYMWNEKIPFC-IUCAKERBSA-N Pro-Gly-Arg Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O DMKWYMWNEKIPFC-IUCAKERBSA-N 0.000 description 2
- OQSGBXGNAFQGGS-CYDGBPFRSA-N Pro-Val-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OQSGBXGNAFQGGS-CYDGBPFRSA-N 0.000 description 2
- IIRBTQHFVNGPMQ-AVGNSLFASA-N Pro-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 IIRBTQHFVNGPMQ-AVGNSLFASA-N 0.000 description 2
- IYCBDVBJWDXQRR-FXQIFTODSA-N Ser-Ala-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O IYCBDVBJWDXQRR-FXQIFTODSA-N 0.000 description 2
- IDQFQFVEWMWRQQ-DLOVCJGASA-N Ser-Ala-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O IDQFQFVEWMWRQQ-DLOVCJGASA-N 0.000 description 2
- OOKCGAYXSNJBGQ-ZLUOBGJFSA-N Ser-Asn-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O OOKCGAYXSNJBGQ-ZLUOBGJFSA-N 0.000 description 2
- YMAWDPHQVABADW-CIUDSAMLSA-N Ser-Gln-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O YMAWDPHQVABADW-CIUDSAMLSA-N 0.000 description 2
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 2
- ZUDXUJSYCCNZQJ-DCAQKATOSA-N Ser-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CO)N ZUDXUJSYCCNZQJ-DCAQKATOSA-N 0.000 description 2
- DJACUBDEDBZKLQ-KBIXCLLPSA-N Ser-Ile-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O DJACUBDEDBZKLQ-KBIXCLLPSA-N 0.000 description 2
- KCGIREHVWRXNDH-GARJFASQSA-N Ser-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N KCGIREHVWRXNDH-GARJFASQSA-N 0.000 description 2
- LRWBCWGEUCKDTN-BJDJZHNGSA-N Ser-Lys-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LRWBCWGEUCKDTN-BJDJZHNGSA-N 0.000 description 2
- PQEQXWRVHQAAKS-SRVKXCTJSA-N Ser-Tyr-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC1=CC=C(O)C=C1 PQEQXWRVHQAAKS-SRVKXCTJSA-N 0.000 description 2
- HSWXBJCBYSWBPT-GUBZILKMSA-N Ser-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(O)=O HSWXBJCBYSWBPT-GUBZILKMSA-N 0.000 description 2
- FQPQPTHMHZKGFM-XQXXSGGOSA-N Thr-Ala-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O FQPQPTHMHZKGFM-XQXXSGGOSA-N 0.000 description 2
- GARULAKWZGFIKC-RWRJDSDZSA-N Thr-Gln-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GARULAKWZGFIKC-RWRJDSDZSA-N 0.000 description 2
- CQNFRKAKGDSJFR-NUMRIWBASA-N Thr-Glu-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O CQNFRKAKGDSJFR-NUMRIWBASA-N 0.000 description 2
- GKWNLDNXMMLRMC-GLLZPBPUSA-N Thr-Glu-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O GKWNLDNXMMLRMC-GLLZPBPUSA-N 0.000 description 2
- SLUWOCTZVGMURC-BFHQHQDPSA-N Thr-Gly-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O SLUWOCTZVGMURC-BFHQHQDPSA-N 0.000 description 2
- JKGGPMOUIAAJAA-YEPSODPASA-N Thr-Gly-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O JKGGPMOUIAAJAA-YEPSODPASA-N 0.000 description 2
- NCXVJIQMWSGRHY-KXNHARMFSA-N Thr-Leu-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O NCXVJIQMWSGRHY-KXNHARMFSA-N 0.000 description 2
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 2
- XKWABWFMQXMUMT-HJGDQZAQSA-N Thr-Pro-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XKWABWFMQXMUMT-HJGDQZAQSA-N 0.000 description 2
- OLFOOYQTTQSSRK-UNQGMJICSA-N Thr-Pro-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OLFOOYQTTQSSRK-UNQGMJICSA-N 0.000 description 2
- MFMGPEKYBXFIRF-SUSMZKCASA-N Thr-Thr-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MFMGPEKYBXFIRF-SUSMZKCASA-N 0.000 description 2
- BZTSQFWJNJYZSX-JRQIVUDYSA-N Thr-Tyr-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O BZTSQFWJNJYZSX-JRQIVUDYSA-N 0.000 description 2
- OGOYMQWIWHGTGH-KZVJFYERSA-N Thr-Val-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O OGOYMQWIWHGTGH-KZVJFYERSA-N 0.000 description 2
- BKVICMPZWRNWOC-RHYQMDGZSA-N Thr-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)O BKVICMPZWRNWOC-RHYQMDGZSA-N 0.000 description 2
- MTEQZJFSEMXXRK-CFMVVWHZSA-N Tyr-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N MTEQZJFSEMXXRK-CFMVVWHZSA-N 0.000 description 2
- XQYHLZNPOTXRMQ-KKUMJFAQSA-N Tyr-Glu-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O XQYHLZNPOTXRMQ-KKUMJFAQSA-N 0.000 description 2
- CVXURBLRELTJKO-BWAGICSOSA-N Tyr-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)O CVXURBLRELTJKO-BWAGICSOSA-N 0.000 description 2
- FDKDGFGTHGJKNV-FHWLQOOXSA-N Tyr-Phe-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N FDKDGFGTHGJKNV-FHWLQOOXSA-N 0.000 description 2
- ZPFLBLFITJCBTP-QWRGUYRKSA-N Tyr-Ser-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)NCC(O)=O ZPFLBLFITJCBTP-QWRGUYRKSA-N 0.000 description 2
- BIVIUZRBCAUNPW-JRQIVUDYSA-N Tyr-Thr-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O BIVIUZRBCAUNPW-JRQIVUDYSA-N 0.000 description 2
- GZWPQZDVTBZVEP-BZSNNMDCSA-N Tyr-Tyr-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O GZWPQZDVTBZVEP-BZSNNMDCSA-N 0.000 description 2
- ASQFIHTXXMFENG-XPUUQOCRSA-N Val-Ala-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O ASQFIHTXXMFENG-XPUUQOCRSA-N 0.000 description 2
- ZLFHAAGHGQBQQN-AEJSXWLSSA-N Val-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZLFHAAGHGQBQQN-AEJSXWLSSA-N 0.000 description 2
- ZLFHAAGHGQBQQN-GUBZILKMSA-N Val-Ala-Pro Natural products CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O ZLFHAAGHGQBQQN-GUBZILKMSA-N 0.000 description 2
- KKHRWGYHBZORMQ-NHCYSSNCSA-N Val-Arg-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KKHRWGYHBZORMQ-NHCYSSNCSA-N 0.000 description 2
- CVUDMNSZAIZFAE-UHFFFAOYSA-N Val-Arg-Pro Natural products NC(N)=NCCCC(NC(=O)C(N)C(C)C)C(=O)N1CCCC1C(O)=O CVUDMNSZAIZFAE-UHFFFAOYSA-N 0.000 description 2
- JTWIMNMUYLQNPI-WPRPVWTQSA-N Val-Gly-Arg Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N JTWIMNMUYLQNPI-WPRPVWTQSA-N 0.000 description 2
- BVWPHWLFGRCECJ-JSGCOSHPSA-N Val-Gly-Tyr Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N BVWPHWLFGRCECJ-JSGCOSHPSA-N 0.000 description 2
- KVRLNEILGGVBJX-IHRRRGAJSA-N Val-His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CN=CN1 KVRLNEILGGVBJX-IHRRRGAJSA-N 0.000 description 2
- VHRLUTIMTDOVCG-PEDHHIEDSA-N Val-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](C(C)C)N VHRLUTIMTDOVCG-PEDHHIEDSA-N 0.000 description 2
- DAVNYIUELQBTAP-XUXIUFHCSA-N Val-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N DAVNYIUELQBTAP-XUXIUFHCSA-N 0.000 description 2
- BZOSBRIDWSSTFN-AVGNSLFASA-N Val-Leu-Met Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](C(C)C)N BZOSBRIDWSSTFN-AVGNSLFASA-N 0.000 description 2
- BTWMICVCQLKKNR-DCAQKATOSA-N Val-Leu-Ser Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C([O-])=O BTWMICVCQLKKNR-DCAQKATOSA-N 0.000 description 2
- MLADEWAIYAPAAU-IHRRRGAJSA-N Val-Lys-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N MLADEWAIYAPAAU-IHRRRGAJSA-N 0.000 description 2
- QRVPEKJBBRYISE-XUXIUFHCSA-N Val-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)N QRVPEKJBBRYISE-XUXIUFHCSA-N 0.000 description 2
- NHXZRXLFOBFMDM-AVGNSLFASA-N Val-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C NHXZRXLFOBFMDM-AVGNSLFASA-N 0.000 description 2
- NLNCNKIVJPEFBC-DLOVCJGASA-N Val-Val-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O NLNCNKIVJPEFBC-DLOVCJGASA-N 0.000 description 2
- AOILQMZPNLUXCM-AVGNSLFASA-N Val-Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN AOILQMZPNLUXCM-AVGNSLFASA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 2
- 108010045023 alanyl-prolyl-tyrosine Proteins 0.000 description 2
- 108010041407 alanylaspartic acid Proteins 0.000 description 2
- 108010005233 alanylglutamic acid Proteins 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 108010047857 aspartylglycine Proteins 0.000 description 2
- 108010068265 aspartyltyrosine Proteins 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 101150073654 dapB gene Proteins 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 108010054813 diprotin B Proteins 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 108010078144 glutaminyl-glycine Proteins 0.000 description 2
- 108010079547 glutamylmethionine Proteins 0.000 description 2
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 2
- 108010027668 glycyl-alanyl-valine Proteins 0.000 description 2
- 108010050475 glycyl-leucyl-tyrosine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 108010037850 glycylvaline Proteins 0.000 description 2
- 108010040030 histidinoalanine Proteins 0.000 description 2
- 108010085325 histidylproline Proteins 0.000 description 2
- 229910001410 inorganic ion Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 2
- 108010078274 isoleucylvaline Proteins 0.000 description 2
- 108010087810 leucyl-seryl-glutamyl-leucine Proteins 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 108010003700 lysyl aspartic acid Proteins 0.000 description 2
- 108010009298 lysylglutamic acid Proteins 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 2
- 108010068488 methionylphenylalanine Proteins 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- SMCWNPAVVQIDBM-UHFFFAOYSA-N piperidine-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCCN1C(O)=O SMCWNPAVVQIDBM-UHFFFAOYSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108010070643 prolylglutamic acid Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- -1 substitution Chemical compound 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000010414 supernatant solution Substances 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- 108010031491 threonyl-lysyl-glutamic acid Proteins 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- UWOCFOFVIBZJGH-YFKPBYRVSA-N (S)-2,3-dihydrodipicolinic acid Chemical compound OC(=O)[C@@H]1CC=CC(C(O)=O)=N1 UWOCFOFVIBZJGH-YFKPBYRVSA-N 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 108010055400 Aspartate kinase Proteins 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 101100465553 Dictyostelium discoideum psmB6 gene Proteins 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- OJNZVYSGVYLQIN-BQBZGAKWSA-N Gly-Met-Asp Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O OJNZVYSGVYLQIN-BQBZGAKWSA-N 0.000 description 1
- ZLCLYFGMKFCDCN-XPUUQOCRSA-N Gly-Ser-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(O)=O ZLCLYFGMKFCDCN-XPUUQOCRSA-N 0.000 description 1
- GJHWILMUOANXTG-WPRPVWTQSA-N Gly-Val-Arg Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GJHWILMUOANXTG-WPRPVWTQSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108010064711 Homoserine dehydrogenase Proteins 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- PARSHQDZROHERM-NHCYSSNCSA-N Ile-Lys-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)N PARSHQDZROHERM-NHCYSSNCSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- LLBQJYDYOLIQAI-JYJNAYRXSA-N Leu-Glu-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LLBQJYDYOLIQAI-JYJNAYRXSA-N 0.000 description 1
- PLOUVAYOMTYJRG-JXUBOQSCSA-N Lys-Thr-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O PLOUVAYOMTYJRG-JXUBOQSCSA-N 0.000 description 1
- FVKRQMQQFGBXHV-QXEWZRGKSA-N Met-Asp-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O FVKRQMQQFGBXHV-QXEWZRGKSA-N 0.000 description 1
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 101100169519 Pyrococcus abyssi (strain GE5 / Orsay) dapAL gene Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CTDPLKMBVALCGN-JSGCOSHPSA-N Tyr-Gly-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O CTDPLKMBVALCGN-JSGCOSHPSA-N 0.000 description 1
- LAYSXAOGWHKNED-XPUUQOCRSA-N Val-Gly-Ser Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LAYSXAOGWHKNED-XPUUQOCRSA-N 0.000 description 1
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000001486 biosynthesis of amino acids Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 241000186254 coryneform bacterium Species 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 101150011371 dapA gene Proteins 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229910001437 manganese ion Inorganic materials 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000007201 ts agar Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
- C12Y103/01—Oxidoreductases acting on the CH-CH group of donors (1.3) with NAD+ or NADP+ as acceptor (1.3.1)
- C12Y103/01026—Dihydrodipicolinate reductase (1.3.1.26)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Definitions
- the present invention relates to dihydrodipicolinate synthase and dihydrodipicolinate reductase derived thermophilic Bacillus bacteria and genes coding for them.
- Dihydrodipicolinate synthase (abbreviated as “DDPS” hereinafter) is an enzyme that synthesizes dihydrodipicolinate through dehydration condensation of aspartic acid semialdehyde and pyruvic acid, and this reaction serves as an entrance of the branching into the L-lysine biosynthesis system in the biosynthesis of amino acids of aspartic acid type.
- dihydrodipicolinate reductase (abbreviated as “DDPR” hereinafter) is known as one of important enzymes of the L-lysine biosynthesis system, which catalyzes the reaction in which the dihydrodipicoliniate generated in the aforementioned reaction is reduced to generate piperidinedicarboxylic acid.
- the gene (dapA) which codes for DDPS has been cloned, and the nucleotide sequence thereof has also be determined.
- methods for producing L-lysine by enhancing DDPS have been disclosed in Japanese Pat. Laid-open Publication (Kokai) No. 56-18596/1981, U.S. Pat. No. 4,346,170 and Applied Microbiology and Biotechnology, 15, pp.227-331 (1982).
- the current mainstream of the L-lysine production is the fermentative production by using a coryneform bacterium or an Escherichia bacterium.
- enzymes required for the fermentation may be inactivated or the production bacteria may be killed due to temperature increase in the medium during the fermentation, and thus it is necessary to cool the medium during the fermentation.
- thermophilic bacteria By the way, enzymes and proteins produced by thermophilic bacteria are generally stable at elevated temperatures, and also stable against pH variation or organic solvents. Therefore, applications thereof as diagnostic regents, industrial catalysts and so forth have been highly developed. If it becomes possible to produce L-lysine by fermentation at elevated temperatures by utilizing such stability and durability of enzymes derived from thermophilic bacteria, the cooling of the medium becomes unnecessary, and therefore the cost for cooling during the fermentation can be reduced. Moreover, if fermentation at elevated temperatures is realized, it is expected that the reaction rate may also be improved
- the present invention is accomplished in view of the aforementioned technical aspect, and its object is to obtain genes of the L-lysine biosynthesis system of thermophilic bacteria and thereby provide novel methods for producing L-lysine.
- the inventors of the present invention assiduously studied in order to achieve the aforementioned object. As a result, they successfully isolated genes that coded for DDPS and DDPR from Bacillus methanolicus, which is one of the thermophilic Bacillus bacteria, and determined the nucleotide sequences of these genes. Thus, they accomplished the present invention.
- the present invention provides the followings.
- a method for producing L-lysine which comprises culturing the microorganism according to (9) in a medium to produce and accumulate L-lysine in the medium, and collecting the L-lysine from the medium.
- the expression of “to have dihydrodipicolinate synthase activity” is used to mean to have an activity for catalyzing the reaction of dehydration condensation of aspartic acid semialdehyde and pyruvic acid to generate dihydrodipicolinate.
- the expression of “to have dihydrodipicolinate reductase activity” is used to mean to have an activity for catalyzing the reaction of reduction of dihydrodipicolinate to generate piperidinedicarboxylic acid, and to mean that the activity is higher at 50° C. than at 37° C.
- DDPS and DDPR which are involved in the L-lysine biosynthesis, with excellent heat resistance, and genes coding for them.
- the DNA of the present invention can be obtained through selection of clones containing a DDPS gene or a DDPR gene based on recovery of auxotrophy in mutant strains of microorganisms deficient in DDPS or DDPR used as an index from a gene library of thermophilic Bacillus bacteria, for example, Bacillus methanolicus.
- a gene library of Bacillus methanolicus can be produced, for example, as follows. First, the total chromosome DNA is prepared by the method of Saito et al. (Saito, H. and Miura, K., Biochem. Biophys. Acta, 72, 619-629, (1963)) or the like from a wild-type strain of Bacillus methanolicus, for example, Bacillus methanolicus PB1 (NCIMB13113) strain, and partially digested with a suitable restriction enzyme, for example, Sau3AI and so forth to obtain a mixture of various fragments. If the degree of the digestion is controlled by adjusting digestion reaction time and so forth, restriction enzymes of a wide range can be used.
- a suitable restriction enzyme for example, Sau3AI and so forth
- the digested chromosome DNA fragments are ligated to vector DNA autonomously replicable within Escherichia coli cells to produce recombinant DNA. More specifically, a restriction enzyme producing the same end nucleotide sequence as the restriction enzyme used for the digestion of the chromosome DNA is allowed to act on the vector DNA to fully digest the vector and cleave it. Then, the mixture of the chromosome DNA fragments and the cleaved vector DNA obtained as described above are mixed, and a DNA ligase, preferably T4 DNA ligase, is allowed to act on the mixture to obtain recombinant DNA.
- a DNA ligase preferably T4 DNA ligase
- Escherichia coli for example, the Escherichia coli JM109 strain and so forth
- a gene library solution can be prepared from culture of obtained transformants.
- the transformation can be performed by, for example, the method of D. M. Morrison (Methods in Enzymology, 68, 326 (1979)) and the method in which recipient cells are treated with calcium chloride so as to increase the permeability of the cells for DNA (Mandel, M. and Higa, A., J. Mol. Biol., 53, 159 (1970)). Electroporation was employed in the examples mentioned below.
- Examples of the vector include, for example, pUC19, pUC18, pBR322, pHSG299, pHSG298, pHSG399, pHSG398, RSF1010, pMW119, pMW118, pMW219, pMW218, pSTV28 and so forth.
- phage vectors can also be used. For example, since a chloramphenicol resistance gene is contained in pSTV28, only transformants harboring the vector or the recombinant DNA can be grown by using a medium containing chloramphenicol when that vector is used.
- Examples of the method for collecting the recombinant DNA from the cells after the transformants are cultured include the alkali SDS method and so forth.
- a mutant strain of microorganism deficient in DDPS or DDPR is transformed, and clones showing recovery of auxotrophy are selected.
- Examples of such a mutant strain of microorganism deficient in DDPS include the Escherichia coli AT998 (CGSC4548) strain, which is deficient in DDPS. Since the Escherichia coli AT998 strain is deficient in the DDPS gene, it cannot grow in a minimal medium that does not contain diaminopimelate.
- a transformant strain thereof which harbors the DDPS gene derived from Bacillus methanolicus can grow in the minimal medium, because the gene functions. Therefore, a DNA fragment containing the DDPS gene can be obtained by selecting a transformant strain that can grow in the minimal medium and collecting recombinant DNA from the strain.
- Examples of the mutant strain of microorganism deficient in DDPR include the Escherichia coli AT999 strain (CGSC 4549), which is deficient in the DDPR gene. Since the Escherichia coli AT999 strain is deficient in the DDPR gene, it shows only a slow growth rate even in a complete medium such as L medium if it does not contain diaminopimelate. On the other hand, a transformant strain thereof which harbors the DDPR gene derived from Bacillus methanolicus shows normal growth, because the gene functions.
- the Escherichia coli AT999 cannot grow in a minimal medium, whereas a transformant strain thereof which harbors the DDPR gene derived from Bacillus methanolicus can grow in the minimal medium, because the gene functions. Therefore, a DNA fragment containing the DDPR gene can be obtained by selecting a transformant strain which can grow in the minimal medium and collecting recombinant DNA from the strain.
- nucleotide sequence and the amino acid sequence of the DDPS gene or the DDPR gene and DDPS or DDPR can be determined.
- Determination of nucleotide sequences, digestion and ligation of DNA and so forth may be attained by those methods commonly used for gene cloning (detailed in, for example, Sambrook J., Fritsch, E. F. and Maniatis, T., 1989, Molecular Cloning: A Laboraroty Manual, Second edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. etc.). They can also be conducted according to instructions attached to reagents such as restriction enzymes and kits.
- the DDPS gene of the present invention codes for DDPS that has the amino acid sequence of SEQ ID NO: 2 shown in Sequence Listing.
- Specific examples of the DDPS gene of the present invention include DNA that has the nucleotide sequence of SEQ ID NO: 1.
- the DDPS gene of the present invention may have a nucleotide sequence including replacement of codons for each amino acid with equivalent codons, so long as the sequence codes for the same amino acid sequence as the amino acid sequence shown as SEQ ID NO: 2.
- the DDPS gene of the present invention may be one coding for a protein which has an amino acid sequence of SEQ ID NO: 2 including substitution, deletion, insertion, addition or inversion of one or several amino acids, or one coding for a protein which has DDPS activity.
- the term “several” amino acids used herein means preferably 1-50 amino acids, more preferably 1-10 amino acids.
- Homology between the DDPS gene of the present invention and a known DDPS gene of Bacillus subtilis ( B. subtilis ) is 65.9% on the basis of the nucleotide sequence, and 64.8% on the basis of the encoded amino acid sequence.
- the DDPR gene of the present invention codes for DDPR that has the amino acid sequence of SEQ ID NO: 4 shown in Sequence Listing.
- Specific examples of the DDPR gene of the present invention include DNA that has the nucleotide sequence of SEQ ID NO: 3.
- the DDPR gene of the present invention may have a nucleotide sequence including replacement of codons for each amino acid with equivalent codons, so long as the sequence codes for the same amino acid sequence as the amino acid sequence shown as SEQ ID NO: 4.
- the DDPR gene of the present invention may be one coding for a protein which has an amino acid sequence of SEQ ID NO: 4 including substitution, deletion, insertion, addition or inversion of one or several amino acids, or one coding for a protein which has DDPR activity.
- the term “several” amino acids used herein means preferably 1-40 amino acids, more preferably 1-10 amino acids.
- Homology between the DDPR gene of the present invention and a known DDPR gene of Bacillus subtilis ( B. subtilis ) is 66.7% on the basis of the nucleotide sequence, and 67.5% on the basis of the encoded amino acid sequence.
- DNA that codes for the substantially same protein as DDPS or DDPR as described above is obtained by modifying the nucleotide sequence, for example, by means of the site-directed mutagenesis method so that one or more amino acid residues at a specific site should contain substitution, deletion, insertion, addition or inversion. DNA modified as described above may also be obtained by conventionally known mutation treatments.
- Such mutation treatments includes a method for treating DNA coding for DDPS or DDPR in vitro, for example, with hydroxylamine or the like, and a method for treating a microorganism, for example, a bacterium belonging to the genus Escherichia, harboring DNA coding for DDPS or DDPR with ultraviolet irradiation or a mutagenizing agent usually used for the mutation treatment such as N-methyl-N′-nitro-N-nitrosoguanidine (NTG) and nitrous acid.
- NTG N-methyl-N′-nitro-N-nitrosoguanidine
- substitution, deletion, insertion, addition, or inversion of nucleotides as described above also includes mutation (mutant or variant) which naturally occurs, for example, due to the individual difference or the difference in species or genus of the microorganism that harbors DDPS or DDPR.
- DNA coding for substantially the same protein as DDPS or DDPR is obtained by expressing DNA having mutation described above in an appropriate cell, and investigating the DDPS or DDPR activity of the expression product.
- DNA coding for substantially the same protein as DDPS or DDPR is also obtained by isolating DNA which is hybridizable with a nucleotide sequence comprising the nucleotide sequence of SEQ ID NO: 1 or 3 shown in Sequence Listing or a part thereof, for example, a probe which can be prepared from the nucleotide sequence of SEQ ID NO: 1 or 3 by PCR, under a stringent condition, and codes for a protein having DDPS or DDPR activity.
- the “stringent condition” referred to herein is a condition under which a so-called specific hybrid is formed, and a non-specific hybrid is not formed. It is difficult to clearly define this condition by using numerical values.
- the stringent condition includes a condition under which DNA's having high homology, for example, DNA's having homology of not less than 40% are hybridized with each other, and DNA's having homology lower than the above are not hybridized with each other.
- the stringent condition is exemplified by a condition under which DNA's are hybridized with each other at a salt concentration corresponding to an ordinary condition of washing in Southern hybridization, i.e., 60° C., 1 ⁇ SSC, 0.1% SDS, preferably 0.1 ⁇ SSC, 0.1% SDS (see, for example, Sambrook, J., Fritsch, E. F. and Maniatis, T., Molecular Cloning: A Laboratory Manual, Second edition, 1989, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. etc.).
- Such genes which are hybridizable under the condition as described above, includes those having a stop codon generated in a coding region of the genes, and those having no activity due to mutation of active center.
- mutants can be easily removed by ligating the genes with a commercially available activity expression vector, and measuring the DDPS or DDPR activity.
- the DDPS activity can be measured by, for example, the method of Yugari et al. (Yugari Y. and Gilvarg C., Journal of Biological Chemistry, 240, 4710 (1962)).
- the DDPS activity can be measured by allowing a reaction of 100 ⁇ l of 500 mM imidazole hydrochloride (pH 7.5), 100 ⁇ l of 20 mM aspartic acid semialdehyde (which can be synthesized by the method described in Black S. and Write N., Journal of Biological Chemistry, 213, 51 (1955)), 100 ⁇ l of 20 mM sodium pyruvate and 100 ⁇ l of an enzyme solution in a total volume of 1 ml and measuring increase of absorbance at 270 nm.
- the DDPR activity can be measured by, for example, the method of Tamir et al. (Tamir H. and Gilvarg C., Journal of Biological Chemistry, 249, 3034 (1974)). Specifically, for example, the DDPR activity can be measured by allowing a reaction of 100 ⁇ l of 500 mM imidazole hydrochloride (pH 7.5), 100 ⁇ l of dihydrodipicolinic acid, 100 ⁇ l of NADPH and 100 ⁇ l of an enzyme solution in a total volume of 1 ml and measuring decrease of absorbance at 340 nm.
- the DNA sequence which codes for DDPS or DDPR can be obtained from Bacillus methanolicus gene library by hybridization using an oligonucleotide probe prepared based on each of the sequences.
- DNA sequences which code for the enzymes can also be obtained by amplification from Bacillus methanolicus chromosome DNA by PCR (polymerase chain reaction) using oligonucleotide primers prepared based on the aforementioned nucleotide sequences.
- the DDPS gene and the DDPR gene of the present invention can be used for production of DDPS and DDPR. That is, DDPS can be produced by introducing DNA containing the DDPS gene into a suitable host cell, and culturing the obtained transformant to allow expression of the DNA. DDPR can be produced by introducing DNA containing the DDPR gene into a suitable host cell, and culturing the obtained transformant to allow expression of the DNA.
- the produced DDPS protein or DDPR protein can be collected from the culture and purified by techniques used for usual purification of proteins such as salting out, solvent precipitation, gel filtration chromatography and ion exchange chromatography.
- the DDPS gene and the DDPR gene can also be utilized for breeding of L-lysine producing bacteria. By introducing the DDPS gene, the DDPR gene or the both into a microorganism, L-lysine biosynthesis is enhanced and thus L-lysine producing ability is improved.
- Examples of the host cell into which the DDPS gene or the DDPR gene is introduced include Escherichia bacteria such as Escherichia coli, coryneform bacteria such as Brevibacterium lactofermentum, Bacillus bacteria such as Bacillus methanolicus and so forth.
- Examples of the vector used for introducing the DDPS gene or the DDPR gene into these hosts include, as for Escherichia bacteria, those mentioned above.
- Examples of coryneform bacteria the following vectors can be mentioned. There are indicated microorganisms which harbors each vector, and accession numbers thereof at international depositories are shown in the parentheses, respectively.
- These vectors are obtained from deposited microorganisms as follows. Cells collected at the logarithmic growth phase are lysed with lysozyme and SDS to give a lysate, from which a supernatant solution is obtained by centrifugation at 30,000 ⁇ g. Polyethylene glycol is added to the supernatant solution to perform fractional purification by means of cesium chloride-ethidium bromide equilibrium density gradient centrifugation.
- Examples of the vector for Bacillus bacteria include, for example, pUB110, pHY300PLK, pHV1248, pE194, pC194, pBC16, pSA0501, pSA2100, pAM77, pT181, pBD6, pBD8, pBD64, pHV14 and so forth.
- Transformation of coryneform bacteria may be performed by the electric pulse method (Sugimoto et al., Japanese Pat. Publication Laid-Open No. 2-207791/1990). Transformation of Bacillus bacteria may be performed by a method of making host sells into the protoplast or spheroplast followed by introducing recombinant DNA into the DNA-recipient cells (Chang, S. and Choen, S. N., Molec. Gen. Genet., 168, 111 (1979); Bibb, M. J., Ward, J. M. and Hopwood, O. A., Nature, 274, 398 (1978); Hinnen, A., Hicks, J. B. and Fink, G. R., Proc. Natl. Acad. Sci., USA, 75, 1929 (1978)).
- the DDPS gene or the DDPR gene to be introduced may be introduced into a host with a promoter proper to the gene, or the structural gene ligated to another promoter may be introduced.
- a promoter include lac promoter, trp promoter, trc promoter, tac promoter, P R promoter and P L promoter of ⁇ phage, tet promoter, amyE promoter, spac promoter and so forth.
- L-lysine can be produced by culturing a microorganism introduced with the DDPS gene or the DDPR gene or the both genes and having L-lysine producing ability in a medium to produce and accumulate L-lysine in the medium, and collecting the L-lysine from the medium.
- medium and culture conditions can suitably be selected according to kind of the host microorganism to be used, usual media can be used, which contain a nitrogen source, inorganic ions and other organic trace amount nutrients as required.
- the carbon source there can be used saccharides such as glucose, lactose, galactose, fructose and hydrolysate of starch, alcohols such as glycerol and sorbitol, organic acids such as fumaric acid, citric acid and succinic acid and so forth.
- saccharides such as glucose, lactose, galactose, fructose and hydrolysate of starch
- alcohols such as glycerol and sorbitol
- organic acids such as fumaric acid, citric acid and succinic acid and so forth.
- methanol can be preferably used as the carbon source.
- inorganic ammonium salts such as ammonium sulfate, ammonium chloride and ammonium phosphate
- organic nitrogen such as soybean hydrolysate, ammonia gas, aqueous ammonia and so forth
- inorganic ions or sources thereof a small amount of potassium phosphate, magnesium sulfate, iron ions, manganese ions and so forth may be added.
- a trace amount organic nutrient it is desirable to add a suitable amount of required substances such as L-homoserine and vitamin B 1 , yeast extract and so forth as required.
- the culture is performed under conditions suitable for growth of a microorganism to be used. In general, it is preferably performed for 16 to 72 hours under an aerobic condition, and the culture temperature is controlled to be 20 to 45° C., and pH to be 5-8.5 during the culture. For adjusting pH, inorganic or organic acidic or alkaline substances, ammonia gas and so forth can be used. Further, when a thermophilic bacterium is used as a host, it can be cultured at a culture temperature of 42 to 60° C.
- Collection of L-lysine from the culture can usually be carried out by using a combination of known techniques such as techniques using ion exchange resins, precipitation methods and so forth.
- the reagents used were obtained from Wako Pure Chemicals or Nakarai Tesque unless otherwise indicated.
- the compositions of the media used in each example are shown below. All the media were subjected to steam sterilization at 120° C. for 20 minutes after the components were dissolved.
- One loop of the Bacillus methanolicus PB1 strain (NCIMB13113) was inoculated into 5 ml of TS medium contained in a test tube, and cultured overnight at 50° C. with shaking. The obtained culture was inoculated into 50 ml of TS medium contained in a 500-ml volume Sakaguchi flask at a concentration of 1%, and cultured at 50° C. for 5-6 hours, and the cells were collected by centrifugation.
- the cells were suspended in 50 ml of TEN solution [solution comprising 50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 20 mM NaCl (pH 8.0)], collected by centrifugation, and suspended again in 5 ml of TEN solution containing 5 mg/ml of lysozyme and 10 ⁇ g/ml of ribonuclease A.
- TEN solution solution comprising 50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 20 mM NaCl (pH 8.0)
- the suspension was maintained at 37° C. for 30 minutes, and then added with proteinase K and sodium laurylsulfate at final concentrations of 10 ⁇ g/ml and 0.5%, respectively.
- the suspension was maintained at 70° C. for 2 hours, then added with an equal volume of a saturated phenol solution (phenol solution saturated with 10 mM Tris-HCl (pH 8.0)), and centrifuged.
- the mixture was centrifuged to obtain an upper layer, which was separated on 0.8% agarose gel.
- a DNA fragment corresponding to 2-8 kilo base pairs (abbreviated as “kbp” hereinafter) was collected from the gel using EASYTRAP (glass powder for collection of DNA, produced by Takara Shuzo) to obtain 50 ⁇ l of a fractionated DNA solution.
- the reaction mixture was added and mixed with an equal volume of the phenol/chloroform solution, and centrifuged. The supernatant was collected, and the same procedure as above was repeated by adding an equal volume of the chloroform solution. The supernatant was added with ⁇ fraction (1/10) ⁇ volume of 3 M sodium acetate (pH 4.8) and 2.5-fold volume of ethanol to precipitate DNA. The precipitate was collected by centrifugation, washed with 70% ethanol, dried under vacuum, and dissolved in TE solution.
- the mixture was immediately added with 0.5 ml of SOC medium, transferred to a sterilized test tube, and cultured at 37° C. for 1 hour with shaking.
- the culture was plated on L agar medium containing 20 ⁇ g/ml of chloramphenicol, and incubated overnight at 37° C.
- the emerged colonies were collected by scraping, inoculated into 50 ml of L medium in a 500-ml volume Sakaguchi flask, and cultured at 37° C. for 2 hours with shaking. Plasmid DNA was extracted from the cultured cells by the alkali SDS method to obtain a gene library solution.
- the Escherichia coli AT998 strain deficient in the DDPS gene (CGSC 4548) was transformed with the aforementioned gene library solution by electroporation as described above. After application of pulse, SOC medium was added to the transformation solution, and the cells were cultured at 37° C. with shaking. The culture was centrifuged, and the cells were washed by suspending them in 5 ml of sterilized water and centrifuging the suspension. This washing procedure was repeated once again, and the cells were suspended in 500 ⁇ l of sterilized water. The suspension was plated on M9 minimal agar medium containing 20 ⁇ g/ml of chloramphenicol, and incubated at 37° C. for 2-3 days.
- the Escherichia coli AT998 strain is deficient in the DDPS gene, it cannot grow on M9 minimal medium not containing diaminopimelic acid.
- a transformant strain thereof which contains the DDPS gene derived from Bacillus methanolicus can grow on M9 minimal medium because the gene functions.
- the recombinant vector was extracted from the emerged colonies, and the inserted fragment was confirmed.
- a transformant with the vector pSTV28 could not grow on M9 minimal medium, whereas the Escherichia coli AT998 strain transformed with the above recombinant plasmid grew on M9 minimal medium.
- the obtained insert contained the DDPS gene.
- the Escherichia coli AT998 strain which harbors the plasmid containing the DDPS gene obtained as described above was designated as Escherichia coli AJ13633.
- the AJ13633 strain was deposited at National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry (postal code 305-8566, 1-3 Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, Japan) on Jul. 26, 1999 as an accession number of FERM P-17485, and transferred from the original deposit to international deposit based on Budapest Treaty on Jul. 14, 2000, and has been deposited as deposition number of FERM BP-7221.
- Plasmid containing the DDPS gene was prepared from the Escherichia coli AJ13633 strain, and the nucleotide sequence of the DDPS gene derived from the Bacillus methanolicus PB1 strain was determined by the dideoxy method.
- the coding region of the determined nucleotide sequence of the DDPS gene was shown as SEQ ID NO: 1.
- the amino acid sequence encoded by the nucleotide sequence is shown as SEQ ID NO: 2.
- Nucleotide and amino acid sequence were analyzed with the Genetyx-Mac computer program (Software Development Co., Tokyo, Japan). The homology analysis was carried out according to the method developed by Lipman and Peason ( Science, 227, 1435-1441, 1985).
- the Escherichia coli AT999 strain deficient in the DDPR gene (CGSC4549) was transformed with a gene library solution prepared in the same manner as Example 1(3) by electroporation in the same manner as described above. After pulse was applied, SOC medium was added to the transformation solution, and the cells were cultured at 37° C. with shaking. Then, the culture was plated on L agar medium containing 20 ⁇ g/ml of chloramphenicol, and incubated at 37° C. overnight. Since the Escherichia coli AT999 strain is deficient in the DDPR gene, it shows very slow growth in L medium that does not contain diaminopimelic acid.
- a transformant strain that contains the DDPR gene derived from Bacillus methanolicus shows normal growth even on L medium, since the gene functions. Further, the AT999 strain cannot grow on M9 minimal medium, whereas a transformant strain thereof that contains the DDPR gene derived from Bacillus methanolicus can grow on M9 minimal medium, since the gene functions.
- a colony normally grown on L medium was cultured on M9 agar medium as streak culture to confirm that the DDPR gene was functioning in the transformant strain. Plasmid was extracted from colonies emerged on M9 medium, and an insert was confirmed. A transformant with the vector pSTV28 could not grow on M9 minimal medium, whereas the Escherichia coli AT998 strain transformed with the above recombinant plasmid grew on M9 minimal medium. Thus, it was confirmed that the obtained insert contained the DDPR gene.
- the Escherichia coli AT999 strain which harbors the plasmid containing the DDPR gene obtained as described above was designated as Escherichia coli AJ13634.
- the AJ13634 strain was deposited at National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry (postal code 305-8566, 1-3 Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, Japan) on Jul. 26, 1999 as an accession number of FERM P-17486, and transferred from the original deposit to international deposit based on Budapest Treaty on Jul. 14, 2000, and has been deposited as deposition number of FERM BP-7222.
- Plasmid containing the DDPR gene was prepared from the Escherichia coli AJ13634 strain, and the nucleotide sequence of the DDPR gene derived from the Bacillus methanolicus PB1 strain was determined by the dideoxy method.
- the coding region of the determined nucleotide sequence of the DDPS gene was shown as SEQ ID NO: 3.
- the amino acid sequence encoded by the nucleotide sequence is shown as SEQ ID NO: 4.
- Nucleotide and amino acid sequence were analyzed with the Genetyx-Mac computer program (Software Development Co., Tokyo, Japan). The homology analysis was carried out according to the method developed by Lipman and Peason ( Science, 227, 1435-1441, 1985).
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
An Escherichia coil mutant strain deficient in dihydrodipicolinate synthase or dihydrodipicolinate reductase is transformed by using a chromosome gene library of Bacillus methanolicus, a transformant strain which can grow on a minimal medium is selected, and recombinant DNA containing DNA which codes for dihydrodipicolinate synthase or dihydrodipicolinate reductase is obtained from the transformant.
Description
- 1. Field of the Invention
- The present invention relates to dihydrodipicolinate synthase and dihydrodipicolinate reductase derived thermophilic Bacillus bacteria and genes coding for them.
- 2. Related Art
- In the production of L-lysine by fermentation, strains isolated from nature or artificial mutants thereof have been used in order to improve the productivity. Many artificial mutant strains that produce L-lysine are known, and many of them are aminoethylcysteine (AEC) resistant strains and belong to the genus Brevibacterium, Corynebacterium, Bacillus or Escherichia. Further, various techniques have been disclosed for increasing the amino acid production, for example, use of a transformant obtained by using recombinant DNA (U.S. Pat. No. 4,278,765).
- Dihydrodipicolinate synthase (abbreviated as “DDPS” hereinafter) is an enzyme that synthesizes dihydrodipicolinate through dehydration condensation of aspartic acid semialdehyde and pyruvic acid, and this reaction serves as an entrance of the branching into the L-lysine biosynthesis system in the biosynthesis of amino acids of aspartic acid type. Further, dihydrodipicolinate reductase (abbreviated as “DDPR” hereinafter) is known as one of important enzymes of the L-lysine biosynthesis system, which catalyzes the reaction in which the dihydrodipicoliniate generated in the aforementioned reaction is reduced to generate piperidinedicarboxylic acid.
- As for microorganisms belonging to the genus Escherichia or Corynebacterium, the gene (dapA) which codes for DDPS has been cloned, and the nucleotide sequence thereof has also be determined. As for the genus Escherichia, methods for producing L-lysine by enhancing DDPS have been disclosed in Japanese Pat. Laid-open Publication (Kokai) No. 56-18596/1981, U.S. Pat. No. 4,346,170 and Applied Microbiology and Biotechnology, 15, pp.227-331 (1982). Furthermore, a method for producing L-lysine using an Escherichia bacterium introduced with DDPS derived form Corynebacterium bacteria, which is known not to suffer feedback inhibition by L-lysine, has been disclosed in Korean Pat. Publication No. 92-8382.
- The gene coding for DDPR (dapB) has also been already obtained from the genus Escherichia (Bouvier, J. et al., J. Biol. Chem., 259, 14829 (1984)) and the genus Corynebacterium (Journal of Bacteriology, 175 (9), 2743-2749 (1993)). Furthermore, there has also been disclosed a method for improving production rate and productivity of L-lysine by enhancing the dapB gene derived from Corynebacterium bacterium together with the aspartokinase gene (WO96/40934).
- The current mainstream of the L-lysine production is the fermentative production by using a coryneform bacterium or an Escherichia bacterium. In this production, however, enzymes required for the fermentation may be inactivated or the production bacteria may be killed due to temperature increase in the medium during the fermentation, and thus it is necessary to cool the medium during the fermentation.
- By the way, enzymes and proteins produced by thermophilic bacteria are generally stable at elevated temperatures, and also stable against pH variation or organic solvents. Therefore, applications thereof as diagnostic regents, industrial catalysts and so forth have been highly developed. If it becomes possible to produce L-lysine by fermentation at elevated temperatures by utilizing such stability and durability of enzymes derived from thermophilic bacteria, the cooling of the medium becomes unnecessary, and therefore the cost for cooling during the fermentation can be reduced. Moreover, if fermentation at elevated temperatures is realized, it is expected that the reaction rate may also be improved
- The present invention is accomplished in view of the aforementioned technical aspect, and its object is to obtain genes of the L-lysine biosynthesis system of thermophilic bacteria and thereby provide novel methods for producing L-lysine.
- The inventors of the present invention assiduously studied in order to achieve the aforementioned object. As a result, they successfully isolated genes that coded for DDPS and DDPR from Bacillus methanolicus, which is one of the thermophilic Bacillus bacteria, and determined the nucleotide sequences of these genes. Thus, they accomplished the present invention.
- That is, the present invention provides the followings.
- (1) A protein defined in the following (A) or (B):
- (A) a protein which has the amino acid sequence of SEQ ID NO: 2 shown in Sequence Listing, or
- (B) a protein which has an amino acid sequence of SEQ ID NO: 2 shown in Sequence Listing including substitution, deletion, insertion, addition or inversion of one or several amino acids, and has dihydrodipicolinate synthase activity.
- (2) A DNA which codes for a protein defined in the following (A) or (B):
- (A) a protein which has the amino acid sequence of SEQ ID NO: 2 shown in Sequence Listing, or
- (B) a protein which has an amino acid sequence of SEQ ID NO: 2 shown in Sequence Listing including substitution, deletion, insertion, addition or inversion of one or several amino acids, and has dihydrodipicolinate synthase activity.
- (3) The DNA according to (2), which is a DNA defined in the following (a) or (b):
- (a) a DNA which has a nucleotide sequence comprising at least the nucleotide sequence of the nucleotide numbers 1 to 924 in SEQ ID NO: 1 shown in Sequence Listing; or
- (b) a DNA which is hybridizable with a nucleotide sequence comprising at least the nucleotide sequence of the nucleotide numbers 1 to 924 in SEQ ID NO: 1 shown in Sequence Listing under a stringent condition, and codes for a protein having dihydrodipicolinate synthase activity.
- (4) The DNA according to (3), wherein the stringent condition is a condition in which washing is performed at 60° C., 1×SSC and 0.1% SDS.
- (5) A protein defined in the following (C) or (D):
- (C) a protein which has the amino acid sequence of SEQ ID NO: 4 shown in Sequence Listing, or
- (D) a protein which has an amino acid sequence of SEQ ID NO: 4 shown in Sequence Listing including substitution, deletion, insertion, addition or inversion of one or several amino acids, and has dihydrodipicolinate reductase activity.
- (6) A DNA which codes for a protein defined in the following (C) or (D):
- (C) a protein which has the amino acid sequence of SEQ ID NO: 4 shown in Sequence Listing, or
- (D) a protein which has an amino acid sequence of SEQ ID NO: 4 shown in Sequence Listing including substitution, deletion, insertion, addition or inversion of one or several amino acids, and has dihydrodipicolinate reductase activity.
- (7) The DNA according to (6), which is a DNA defined in the following (c) or (d):
- (c) a DNA which has a nucleotide sequence comprising at least the nucleotide sequence of the nucleotide numbers 1 to 798 in SEQ ID NO: 3 shown in Sequence Listing; or
- (d) a DNA which is hybridizable with a nucleotide sequence comprising at least the nucleotide sequence of the nucleotide numbers 1 to 798 in SEQ ID NO: 3 shown in Sequence Listing under a stringent condition, and codes for a protein having dihydrodipicolinate reductase activity.
- (8) The DNA according to (7), wherein the stringent condition is a condition in which washing is performed at 60° C., 1×SSC and 0.1% SDS.
- (9) A microorganism which is introduced with the DNA according to (2) or the DNA according to (6) or the both in a form that allows expression of a protein encoded by each DNA.
- (10) A method for producing L-lysine, which comprises culturing the microorganism according to (9) in a medium to produce and accumulate L-lysine in the medium, and collecting the L-lysine from the medium.
- In the present invention, the expression of “to have dihydrodipicolinate synthase activity” is used to mean to have an activity for catalyzing the reaction of dehydration condensation of aspartic acid semialdehyde and pyruvic acid to generate dihydrodipicolinate. The expression of “to have dihydrodipicolinate reductase activity” is used to mean to have an activity for catalyzing the reaction of reduction of dihydrodipicolinate to generate piperidinedicarboxylic acid, and to mean that the activity is higher at 50° C. than at 37° C.
- According to the present invention, there are provided DDPS and DDPR, which are involved in the L-lysine biosynthesis, with excellent heat resistance, and genes coding for them.
- Hereafter, the present invention will be explained in detail.
- The DNA of the present invention can be obtained through selection of clones containing a DDPS gene or a DDPR gene based on recovery of auxotrophy in mutant strains of microorganisms deficient in DDPS or DDPR used as an index from a gene library of thermophilic Bacillus bacteria, for example, Bacillus methanolicus.
- The method for obtaining the DNA of the present invention will be explained below.
- <1> Production of Gene Library of Bacillus methanolicus
- A gene library of Bacillus methanolicus can be produced, for example, as follows. First, the total chromosome DNA is prepared by the method of Saito et al. (Saito, H. and Miura, K., Biochem. Biophys. Acta, 72, 619-629, (1963)) or the like from a wild-type strain of Bacillus methanolicus, for example, Bacillus methanolicus PB1 (NCIMB13113) strain, and partially digested with a suitable restriction enzyme, for example, Sau3AI and so forth to obtain a mixture of various fragments. If the degree of the digestion is controlled by adjusting digestion reaction time and so forth, restriction enzymes of a wide range can be used.
- Subsequently, the digested chromosome DNA fragments are ligated to vector DNA autonomously replicable within Escherichia coli cells to produce recombinant DNA. More specifically, a restriction enzyme producing the same end nucleotide sequence as the restriction enzyme used for the digestion of the chromosome DNA is allowed to act on the vector DNA to fully digest the vector and cleave it. Then, the mixture of the chromosome DNA fragments and the cleaved vector DNA obtained as described above are mixed, and a DNA ligase, preferably T4 DNA ligase, is allowed to act on the mixture to obtain recombinant DNA.
- By using the obtained recombinant DNA, Escherichia coli, for example, the Escherichia coli JM109 strain and so forth, is transformed, and a gene library solution can be prepared from culture of obtained transformants. The transformation can be performed by, for example, the method of D. M. Morrison (Methods in Enzymology, 68, 326 (1979)) and the method in which recipient cells are treated with calcium chloride so as to increase the permeability of the cells for DNA (Mandel, M. and Higa, A., J. Mol. Biol., 53, 159 (1970)). Electroporation was employed in the examples mentioned below.
- Examples of the vector include, for example, pUC19, pUC18, pBR322, pHSG299, pHSG298, pHSG399, pHSG398, RSF1010, pMW119, pMW118, pMW219, pMW218, pSTV28 and so forth. In addition, phage vectors can also be used. For example, since a chloramphenicol resistance gene is contained in pSTV28, only transformants harboring the vector or the recombinant DNA can be grown by using a medium containing chloramphenicol when that vector is used.
- Examples of the method for collecting the recombinant DNA from the cells after the transformants are cultured include the alkali SDS method and so forth.
- <2> Screening of Clones Containing DDPS Gene or DDPR Gene
- By using a gene library solution of Bacillus methanolicus obtained as described above, a mutant strain of microorganism deficient in DDPS or DDPR is transformed, and clones showing recovery of auxotrophy are selected. Examples of such a mutant strain of microorganism deficient in DDPS include the Escherichia coli AT998 (CGSC4548) strain, which is deficient in DDPS. Since the Escherichia coli AT998 strain is deficient in the DDPS gene, it cannot grow in a minimal medium that does not contain diaminopimelate. On the other hand, a transformant strain thereof which harbors the DDPS gene derived from Bacillus methanolicus can grow in the minimal medium, because the gene functions. Therefore, a DNA fragment containing the DDPS gene can be obtained by selecting a transformant strain that can grow in the minimal medium and collecting recombinant DNA from the strain.
- Examples of the mutant strain of microorganism deficient in DDPR include the Escherichia coli AT999 strain (CGSC 4549), which is deficient in the DDPR gene. Since the Escherichia coli AT999 strain is deficient in the DDPR gene, it shows only a slow growth rate even in a complete medium such as L medium if it does not contain diaminopimelate. On the other hand, a transformant strain thereof which harbors the DDPR gene derived from Bacillus methanolicus shows normal growth, because the gene functions. Further, the Escherichia coli AT999 cannot grow in a minimal medium, whereas a transformant strain thereof which harbors the DDPR gene derived from Bacillus methanolicus can grow in the minimal medium, because the gene functions. Therefore, a DNA fragment containing the DDPR gene can be obtained by selecting a transformant strain which can grow in the minimal medium and collecting recombinant DNA from the strain.
- By extracting an inserted DNA fragment from the obtained recombinant DNA and determining nucleotide sequence of the fragment, the nucleotide sequence and the amino acid sequence of the DDPS gene or the DDPR gene and DDPS or DDPR can be determined.
- Determination of nucleotide sequences, digestion and ligation of DNA and so forth may be attained by those methods commonly used for gene cloning (detailed in, for example, Sambrook J., Fritsch, E. F. and Maniatis, T., 1989, Molecular Cloning: A Laboraroty Manual, Second edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. etc.). They can also be conducted according to instructions attached to reagents such as restriction enzymes and kits.
- The DDPS gene of the present invention codes for DDPS that has the amino acid sequence of SEQ ID NO: 2 shown in Sequence Listing. Specific examples of the DDPS gene of the present invention include DNA that has the nucleotide sequence of SEQ ID NO: 1. Further, the DDPS gene of the present invention may have a nucleotide sequence including replacement of codons for each amino acid with equivalent codons, so long as the sequence codes for the same amino acid sequence as the amino acid sequence shown as SEQ ID NO: 2.
- Further, the DDPS gene of the present invention may be one coding for a protein which has an amino acid sequence of SEQ ID NO: 2 including substitution, deletion, insertion, addition or inversion of one or several amino acids, or one coding for a protein which has DDPS activity. The term “several” amino acids used herein means preferably 1-50 amino acids, more preferably 1-10 amino acids. Homology between the DDPS gene of the present invention and a known DDPS gene of Bacillus subtilis (B. subtilis) is 65.9% on the basis of the nucleotide sequence, and 64.8% on the basis of the encoded amino acid sequence.
- The DDPR gene of the present invention codes for DDPR that has the amino acid sequence of SEQ ID NO: 4 shown in Sequence Listing. Specific examples of the DDPR gene of the present invention include DNA that has the nucleotide sequence of SEQ ID NO: 3. Further, the DDPR gene of the present invention may have a nucleotide sequence including replacement of codons for each amino acid with equivalent codons, so long as the sequence codes for the same amino acid sequence as the amino acid sequence shown as SEQ ID NO: 4.
- Further, the DDPR gene of the present invention may be one coding for a protein which has an amino acid sequence of SEQ ID NO: 4 including substitution, deletion, insertion, addition or inversion of one or several amino acids, or one coding for a protein which has DDPR activity. The term “several” amino acids used herein means preferably 1-40 amino acids, more preferably 1-10 amino acids. Homology between the DDPR gene of the present invention and a known DDPR gene of Bacillus subtilis (B. subtilis) is 66.7% on the basis of the nucleotide sequence, and 67.5% on the basis of the encoded amino acid sequence.
- DNA that codes for the substantially same protein as DDPS or DDPR as described above is obtained by modifying the nucleotide sequence, for example, by means of the site-directed mutagenesis method so that one or more amino acid residues at a specific site should contain substitution, deletion, insertion, addition or inversion. DNA modified as described above may also be obtained by conventionally known mutation treatments. Such mutation treatments includes a method for treating DNA coding for DDPS or DDPR in vitro, for example, with hydroxylamine or the like, and a method for treating a microorganism, for example, a bacterium belonging to the genus Escherichia, harboring DNA coding for DDPS or DDPR with ultraviolet irradiation or a mutagenizing agent usually used for the mutation treatment such as N-methyl-N′-nitro-N-nitrosoguanidine (NTG) and nitrous acid.
- The substitution, deletion, insertion, addition, or inversion of nucleotides as described above also includes mutation (mutant or variant) which naturally occurs, for example, due to the individual difference or the difference in species or genus of the microorganism that harbors DDPS or DDPR.
- Such DNA coding for substantially the same protein as DDPS or DDPR is obtained by expressing DNA having mutation described above in an appropriate cell, and investigating the DDPS or DDPR activity of the expression product. DNA coding for substantially the same protein as DDPS or DDPR is also obtained by isolating DNA which is hybridizable with a nucleotide sequence comprising the nucleotide sequence of SEQ ID NO: 1 or 3 shown in Sequence Listing or a part thereof, for example, a probe which can be prepared from the nucleotide sequence of SEQ ID NO: 1 or 3 by PCR, under a stringent condition, and codes for a protein having DDPS or DDPR activity.
- The “stringent condition” referred to herein is a condition under which a so-called specific hybrid is formed, and a non-specific hybrid is not formed. It is difficult to clearly define this condition by using numerical values. However, for example, the stringent condition includes a condition under which DNA's having high homology, for example, DNA's having homology of not less than 40% are hybridized with each other, and DNA's having homology lower than the above are not hybridized with each other. Alternatively, the stringent condition is exemplified by a condition under which DNA's are hybridized with each other at a salt concentration corresponding to an ordinary condition of washing in Southern hybridization, i.e., 60° C., 1×SSC, 0.1% SDS, preferably 0.1×SSC, 0.1% SDS (see, for example, Sambrook, J., Fritsch, E. F. and Maniatis, T., Molecular Cloning: A Laboratory Manual, Second edition, 1989, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. etc.).
- Such genes, which are hybridizable under the condition as described above, includes those having a stop codon generated in a coding region of the genes, and those having no activity due to mutation of active center. However, such mutants can be easily removed by ligating the genes with a commercially available activity expression vector, and measuring the DDPS or DDPR activity. The DDPS activity can be measured by, for example, the method of Yugari et al. (Yugari Y. and Gilvarg C., Journal of Biological Chemistry, 240, 4710 (1962)). Specifically, for example, the DDPS activity can be measured by allowing a reaction of 100 μl of 500 mM imidazole hydrochloride (pH 7.5), 100 μl of 20 mM aspartic acid semialdehyde (which can be synthesized by the method described in Black S. and Write N., Journal of Biological Chemistry, 213, 51 (1955)), 100 μl of 20 mM sodium pyruvate and 100 μl of an enzyme solution in a total volume of 1 ml and measuring increase of absorbance at 270 nm.
- The DDPR activity can be measured by, for example, the method of Tamir et al. (Tamir H. and Gilvarg C., Journal of Biological Chemistry, 249, 3034 (1974)). Specifically, for example, the DDPR activity can be measured by allowing a reaction of 100 μl of 500 mM imidazole hydrochloride (pH 7.5), 100 μl of dihydrodipicolinic acid, 100 μl of NADPH and 100 μl of an enzyme solution in a total volume of 1 ml and measuring decrease of absorbance at 340 nm.
- Because the nucleotide sequences of the genes which code for DDPS and DDPR derived from Bacillus methanolicus were elucidated by the present invention, the DNA sequence which codes for DDPS or DDPR can be obtained from Bacillus methanolicus gene library by hybridization using an oligonucleotide probe prepared based on each of the sequences. DNA sequences which code for the enzymes can also be obtained by amplification from Bacillus methanolicus chromosome DNA by PCR (polymerase chain reaction) using oligonucleotide primers prepared based on the aforementioned nucleotide sequences.
- <3> Application of DDPS Gene and DDPR Gene
- The DDPS gene and the DDPR gene of the present invention can be used for production of DDPS and DDPR. That is, DDPS can be produced by introducing DNA containing the DDPS gene into a suitable host cell, and culturing the obtained transformant to allow expression of the DNA. DDPR can be produced by introducing DNA containing the DDPR gene into a suitable host cell, and culturing the obtained transformant to allow expression of the DNA. The produced DDPS protein or DDPR protein can be collected from the culture and purified by techniques used for usual purification of proteins such as salting out, solvent precipitation, gel filtration chromatography and ion exchange chromatography.
- The DDPS gene and the DDPR gene can also be utilized for breeding of L-lysine producing bacteria. By introducing the DDPS gene, the DDPR gene or the both into a microorganism, L-lysine biosynthesis is enhanced and thus L-lysine producing ability is improved.
- Examples of the host cell into which the DDPS gene or the DDPR gene is introduced include Escherichia bacteria such as Escherichia coli, coryneform bacteria such as Brevibacterium lactofermentum, Bacillus bacteria such as Bacillus methanolicus and so forth. Examples of the vector used for introducing the DDPS gene or the DDPR gene into these hosts include, as for Escherichia bacteria, those mentioned above. As for coryneform bacteria, the following vectors can be mentioned. There are indicated microorganisms which harbors each vector, and accession numbers thereof at international depositories are shown in the parentheses, respectively.
pAJ655 Escherichia coli AJ11882 (FERM BP-136) Corynebacterium glutamicum SR8201 (ATCC39135) pAJ1844 Escherichia coli AJ11883 (FERM BP-137) Corynebacterium glutamicum SR8202 (ATCC39136) pAJ611 Escherichia coli AJ11884 (FERM BP-138) pAJ3148 Corynebacterium glutamicum SR8203 (ATCC39137) pAJ440 Bacillus subtilis AJ11901 (FERM BP-140) - These vectors are obtained from deposited microorganisms as follows. Cells collected at the logarithmic growth phase are lysed with lysozyme and SDS to give a lysate, from which a supernatant solution is obtained by centrifugation at 30,000×g. Polyethylene glycol is added to the supernatant solution to perform fractional purification by means of cesium chloride-ethidium bromide equilibrium density gradient centrifugation.
- In order to introduce a plasmid into E. coli to transform it, there may be used a method in which recipient cells are treated with calcium chloride so as to increase the permeability of the cells for DNA (Mandel, M. and Higa, A., J. Mol. Biol., 53, 159 (1970)) and so forth.
- Examples of the vector for Bacillus bacteria include, for example, pUB110, pHY300PLK, pHV1248, pE194, pC194, pBC16, pSA0501, pSA2100, pAM77, pT181, pBD6, pBD8, pBD64, pHV14 and so forth.
- Transformation of coryneform bacteria may be performed by the electric pulse method (Sugimoto et al., Japanese Pat. Publication Laid-Open No. 2-207791/1990). Transformation of Bacillus bacteria may be performed by a method of making host sells into the protoplast or spheroplast followed by introducing recombinant DNA into the DNA-recipient cells (Chang, S. and Choen, S. N., Molec. Gen. Genet., 168, 111 (1979); Bibb, M. J., Ward, J. M. and Hopwood, O. A., Nature, 274, 398 (1978); Hinnen, A., Hicks, J. B. and Fink, G. R., Proc. Natl. Acad. Sci., USA, 75, 1929 (1978)).
- The DDPS gene or the DDPR gene to be introduced may be introduced into a host with a promoter proper to the gene, or the structural gene ligated to another promoter may be introduced. Examples of such a promoter include lac promoter, trp promoter, trc promoter, tac promoter, P R promoter and PL promoter of λ phage, tet promoter, amyE promoter, spac promoter and so forth.
- L-lysine can be produced by culturing a microorganism introduced with the DDPS gene or the DDPR gene or the both genes and having L-lysine producing ability in a medium to produce and accumulate L-lysine in the medium, and collecting the L-lysine from the medium.
- Although medium and culture conditions can suitably be selected according to kind of the host microorganism to be used, usual media can be used, which contain a nitrogen source, inorganic ions and other organic trace amount nutrients as required.
- As the carbon source, there can be used saccharides such as glucose, lactose, galactose, fructose and hydrolysate of starch, alcohols such as glycerol and sorbitol, organic acids such as fumaric acid, citric acid and succinic acid and so forth.
- When a methanol assimilating bacterium such as Bacillus methanolicus is used as the microorganism of the present invention, methanol can be preferably used as the carbon source.
- As the nitrogen source, inorganic ammonium salts such as ammonium sulfate, ammonium chloride and ammonium phosphate, organic nitrogen such as soybean hydrolysate, ammonia gas, aqueous ammonia and so forth can be used.
- As the inorganic ions or sources thereof, a small amount of potassium phosphate, magnesium sulfate, iron ions, manganese ions and so forth may be added. As a trace amount organic nutrient, it is desirable to add a suitable amount of required substances such as L-homoserine and vitamin B 1, yeast extract and so forth as required.
- The culture is performed under conditions suitable for growth of a microorganism to be used. In general, it is preferably performed for 16 to 72 hours under an aerobic condition, and the culture temperature is controlled to be 20 to 45° C., and pH to be 5-8.5 during the culture. For adjusting pH, inorganic or organic acidic or alkaline substances, ammonia gas and so forth can be used. Further, when a thermophilic bacterium is used as a host, it can be cultured at a culture temperature of 42 to 60° C.
- Collection of L-lysine from the culture can usually be carried out by using a combination of known techniques such as techniques using ion exchange resins, precipitation methods and so forth.
- Hereafter, the present invention will be further specifically explained with reference to the following examples.
- The reagents used were obtained from Wako Pure Chemicals or Nakarai Tesque unless otherwise indicated. The compositions of the media used in each example are shown below. All the media were subjected to steam sterilization at 120° C. for 20 minutes after the components were dissolved.
[L medium] Bacto trypton (DIFCO) 1% Yeast extract (DIFCO) 0.5% NaCl 0.5% [L agar medium] L medium Bacto agar (DIFCO) 1.5% [SOC medium] Bacto trypton (DIFCO) 2% Yeast extract (DIFCO) 0.5% NaCl 10 mM KCl 2.5 mM MgSO4 10 mM MgCl2 10 mM Glucose 20 mM [The components except for magnesium solution and glucose were steam-sterilized, then added with 2 M magnesium stock solution (1 M MgSO4, 1 M MgCl2) and 2 M glucose solution, which solutions had been passed through a 0.22 μm filter beforehand, and passed through a 0.22 μm filter again.] [TS medium] Bacto trypton (DIFCO) 1.5% Bacto soyton (DIFCO) 0.5% NaCl 0.5% [TS agar medium] TS medium Bacto agar (DIFCO) 1.5% [M9 minimal medium] Na2HPO4.12H2O 8% KH2PO4 1.5% NaCl 2.5% NH4Cl 0.5% MgSO4.7H2O 246.48 mg/L Glucose 0.5% pH 7.0 [MgSO4 and glucose were separately sterilized and added. A suitable amount of amino acids and vitamins were added as required.] [M9 minimal agar medium] M9 minimal medium Bacto agar (DIFCO) 1.5% - (1) Preparation of Chromosome DNA from Bacillus methanolicus
- One loop of the Bacillus methanolicus PB1 strain (NCIMB13113) was inoculated into 5 ml of TS medium contained in a test tube, and cultured overnight at 50° C. with shaking. The obtained culture was inoculated into 50 ml of TS medium contained in a 500-ml volume Sakaguchi flask at a concentration of 1%, and cultured at 50° C. for 5-6 hours, and the cells were collected by centrifugation. The cells were suspended in 50 ml of TEN solution [solution comprising 50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 20 mM NaCl (pH 8.0)], collected by centrifugation, and suspended again in 5 ml of TEN solution containing 5 mg/ml of lysozyme and 10 μg/ml of ribonuclease A.
- The suspension was maintained at 37° C. for 30 minutes, and then added with proteinase K and sodium laurylsulfate at final concentrations of 10 μg/ml and 0.5%, respectively. The suspension was maintained at 70° C. for 2 hours, then added with an equal volume of a saturated phenol solution (phenol solution saturated with 10 mM Tris-HCl (pH 8.0)), and centrifuged. The supernatant was collected, added and mixed with an equal volume of a phenol/chloroform solution (phenol:chloroform:isoamyl alcohol=25:24:1), and centrifuged.
- The supernatant was collected, and the same procedure as above was repeated by adding an equal volume of a chloroform solution (chloroform:isoamyl alcohol=24:1). The supernatant was added with {fraction (1/10)} volume of 3 M sodium acetate (pH 4.8) and 2.5-fold volume of ethanol to precipitate chromosome DNA. The precipitate was collected by centrifugation, washed with 70% ethanol, dried under vacuum, and dissolved in an appropriate amount of TE solution (10 mM Tris-HCl, 1 mM EDTA (pH 8.0)).
- (2) Ligation of Vector DNA and Chromosome DNA
- 50 μl of the chromosome DNA (1 μg/μl) obtained in the above (1), 20 μl of H buffer (500 mM Tris-HCl, 100 mM MgCl 2, 10 mM dithiothreitol, 1000 mM NaCl (pH 7.5)) and 8 units of restriction enzyme Sau3AI (Takara Shuzo) were allowed to react in a total volume of 200 μl at 37° C. for 10 minutes, and then the reaction mixture was mixed with 200 μl of the phenol/chloroform solution to stop the reaction.
- The mixture was centrifuged to obtain an upper layer, which was separated on 0.8% agarose gel. A DNA fragment corresponding to 2-8 kilo base pairs (abbreviated as “kbp” hereinafter) was collected from the gel using EASYTRAP (glass powder for collection of DNA, produced by Takara Shuzo) to obtain 50 μl of a fractionated DNA solution.
- Separately, 5 μl of 0.5 μg/μl plasmid pSTV28 (produced by Takara Shuzo), 2 μl of K buffer (200 mM Tris-HCl, 100 mM MgCl 2, 10 mM dithiothreitol, 1000 mM KCl (pH 8.5)) and 10 units of restriction enzyme BamHI (produced by Takara Shuzo) were allowed to react in a total volume of 20 μl at 37° C. for 2 hours, then added with 20 units of calf small intestine alkaline phosphatase (produced by Takara Shuzo), and further allowed to react for 30 minutes. The reaction mixture was added and mixed with an equal volume of the phenol/chloroform solution, and centrifuged. The supernatant was collected, and the same procedure as above was repeated by adding an equal volume of the chloroform solution. The supernatant was added with {fraction (1/10)} volume of 3 M sodium acetate (pH 4.8) and 2.5-fold volume of ethanol to precipitate DNA. The precipitate was collected by centrifugation, washed with 70% ethanol, dried under vacuum, and dissolved in TE solution.
- The Sau3AI digest of the chromosome DNA fractionated in the above (1) and the BamHI digest of pSTV28 were ligated by using Ligation Kit ver. 2 (Takara Shuzo). The ligation reaction mixture was added with {fraction (1/10)} volume of 3 M sodium acetate (pH 4.8) and 2.5-fold volume of ethanol were added to precipitate DNA. The precipitate was collected by centrifugation, washed with 70% ethanol, dried under vacuum, and dissolved in TE solution.
- (3) Preparation of Gene Library
- One loop of Escherichia coli JM109 was inoculated into 5 ml of L medium contained in a test tube, and cultured overnight at 37° C. with shaking. The obtained culture was inoculated into 50 ml of L medium contained in a 500-ml volume Sakaguchi flask at a concentration of 1%, and cultured at 37° C. until OD660 reached 0.5-0.6. The culture was cooled on ice for 15 minutes, and centrifuged at 4° C. to collect the cells. The cells were washed by suspending them in 50 ml of ice-cooled water and subjecting the suspension to centrifugation. This procedure was repeated once again, and the cells were washed by suspending them in 50 ml of 10% glycerol solution cooled with ice and subjecting the suspension to centrifugation. The cells were suspended in an equal volume of 10% glycerol solution, and divided into portions of 50 μl volume. To 50 μl of the cell, 1 μl of the ligation solution prepared above was added, and the mixture was transferred to a cuvette (for exclusive use in an electroporation apparatus of BioRad Co., width of 0.1 cm) cooled with ice beforehand. Conditions of the electroporation apparatus were set at 1.8 kV and 25 μF, and the pulse controller was set at 200 ohms. The cuvette was mounted on the apparatus and pulse was applied. After the application of the pulse, the mixture was immediately added with 0.5 ml of SOC medium, transferred to a sterilized test tube, and cultured at 37° C. for 1 hour with shaking. The culture was plated on L agar medium containing 20 μg/ml of chloramphenicol, and incubated overnight at 37° C.
- The emerged colonies were collected by scraping, inoculated into 50 ml of L medium in a 500-ml volume Sakaguchi flask, and cultured at 37° C. for 2 hours with shaking. Plasmid DNA was extracted from the cultured cells by the alkali SDS method to obtain a gene library solution.
- (4) Isolation of Clone with DDPS Gene
- The Escherichia coli AT998 strain deficient in the DDPS gene (CGSC 4548) was transformed with the aforementioned gene library solution by electroporation as described above. After application of pulse, SOC medium was added to the transformation solution, and the cells were cultured at 37° C. with shaking. The culture was centrifuged, and the cells were washed by suspending them in 5 ml of sterilized water and centrifuging the suspension. This washing procedure was repeated once again, and the cells were suspended in 500 μl of sterilized water. The suspension was plated on M9 minimal agar medium containing 20 μg/ml of chloramphenicol, and incubated at 37° C. for 2-3 days. Because the Escherichia coli AT998 strain is deficient in the DDPS gene, it cannot grow on M9 minimal medium not containing diaminopimelic acid. However, a transformant strain thereof which contains the DDPS gene derived from Bacillus methanolicus can grow on M9 minimal medium because the gene functions.
- The recombinant vector was extracted from the emerged colonies, and the inserted fragment was confirmed. A transformant with the vector pSTV28 could not grow on M9 minimal medium, whereas the Escherichia coli AT998 strain transformed with the above recombinant plasmid grew on M9 minimal medium. Thus, it was confirmed that the obtained insert contained the DDPS gene.
- The Escherichia coli AT998 strain which harbors the plasmid containing the DDPS gene obtained as described above was designated as Escherichia coli AJ13633. The AJ13633 strain was deposited at National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry (postal code 305-8566, 1-3 Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, Japan) on Jul. 26, 1999 as an accession number of FERM P-17485, and transferred from the original deposit to international deposit based on Budapest Treaty on Jul. 14, 2000, and has been deposited as deposition number of FERM BP-7221.
- (5) Determination of Nucleotide Sequence of DDPS Gene
- Plasmid containing the DDPS gene was prepared from the Escherichia coli AJ13633 strain, and the nucleotide sequence of the DDPS gene derived from the Bacillus methanolicus PB1 strain was determined by the dideoxy method. The coding region of the determined nucleotide sequence of the DDPS gene was shown as SEQ ID NO: 1. The amino acid sequence encoded by the nucleotide sequence is shown as SEQ ID NO: 2. Nucleotide and amino acid sequence were analyzed with the Genetyx-Mac computer program (Software Development Co., Tokyo, Japan). The homology analysis was carried out according to the method developed by Lipman and Peason (Science, 227, 1435-1441, 1985). As a result of the homology search, since this amino acid sequence showed a high homology of 64.8% with respect to DDPS derived from Bacillus subtilis belonging to the genus Bacillus like Bacillus methanolicus, the obtained gene was identified to be the DDPS gene derived from Bacillus methanolicus.
- (1) Isolation of Clone with DDPR Gene
- The Escherichia coli AT999 strain deficient in the DDPR gene (CGSC4549) was transformed with a gene library solution prepared in the same manner as Example 1(3) by electroporation in the same manner as described above. After pulse was applied, SOC medium was added to the transformation solution, and the cells were cultured at 37° C. with shaking. Then, the culture was plated on L agar medium containing 20 μg/ml of chloramphenicol, and incubated at 37° C. overnight. Since the Escherichia coli AT999 strain is deficient in the DDPR gene, it shows very slow growth in L medium that does not contain diaminopimelic acid. However, a transformant strain that contains the DDPR gene derived from Bacillus methanolicus shows normal growth even on L medium, since the gene functions. Further, the AT999 strain cannot grow on M9 minimal medium, whereas a transformant strain thereof that contains the DDPR gene derived from Bacillus methanolicus can grow on M9 minimal medium, since the gene functions.
- A colony normally grown on L medium was cultured on M9 agar medium as streak culture to confirm that the DDPR gene was functioning in the transformant strain. Plasmid was extracted from colonies emerged on M9 medium, and an insert was confirmed. A transformant with the vector pSTV28 could not grow on M9 minimal medium, whereas the Escherichia coli AT998 strain transformed with the above recombinant plasmid grew on M9 minimal medium. Thus, it was confirmed that the obtained insert contained the DDPR gene.
- The Escherichia coli AT999 strain which harbors the plasmid containing the DDPR gene obtained as described above was designated as Escherichia coli AJ13634. The AJ13634 strain was deposited at National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry (postal code 305-8566, 1-3 Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, Japan) on Jul. 26, 1999 as an accession number of FERM P-17486, and transferred from the original deposit to international deposit based on Budapest Treaty on Jul. 14, 2000, and has been deposited as deposition number of FERM BP-7222.
- (2) Determination of Nucleotide Sequence of DDPR Gene
- Plasmid containing the DDPR gene was prepared from the Escherichia coli AJ13634 strain, and the nucleotide sequence of the DDPR gene derived from the Bacillus methanolicus PB1 strain was determined by the dideoxy method. The coding region of the determined nucleotide sequence of the DDPS gene was shown as SEQ ID NO: 3. The amino acid sequence encoded by the nucleotide sequence is shown as SEQ ID NO: 4. Nucleotide and amino acid sequence were analyzed with the Genetyx-Mac computer program (Software Development Co., Tokyo, Japan). The homology analysis was carried out according to the method developed by Lipman and Peason (Science, 227, 1435-1441, 1985). As a result of the homology search, since this amino acid sequence showed a high homology of 67.5% with respect to DDPR derived from Bacillus subtilis belonging to the genus Bacillus like Bacillus methanolicus, the obtained gene was identified to be the DDPR gene derived from Bacillus methanolicus.
-
1 4 1 873 DNA Bacillus methanolicus CDS (1)..(870) 1 atg gtt tct ttt ggt cga ata tca aca gct atg gtt aca cca ttt gat 48 Met Val Ser Phe Gly Arg Ile Ser Thr Ala Met Val Thr Pro Phe Asp 1 5 10 15 aac aaa ggt cat att gat ttt gca aaa aca acg caa ctc gtg aat cat 96 Asn Lys Gly His Ile Asp Phe Ala Lys Thr Thr Gln Leu Val Asn His 20 25 30 tta att aat aat ggt tca gat tct tta gtt gtt gtc ggt act act gga 144 Leu Ile Asn Asn Gly Ser Asp Ser Leu Val Val Val Gly Thr Thr Gly 35 40 45 gag tca gcc aca ctt aca aaa gaa gaa aaa ttg gcg ctt ttt cag cat 192 Glu Ser Ala Thr Leu Thr Lys Glu Glu Lys Leu Ala Leu Phe Gln His 50 55 60 gta gta aaa gta gtt gaa aaa aga gtc cct gtt att gca ggc acc gga 240 Val Val Lys Val Val Glu Lys Arg Val Pro Val Ile Ala Gly Thr Gly 65 70 75 80 agc aat aat act tat gat tca atc gaa atg aca aaa aaa gca gaa aaa 288 Ser Asn Asn Thr Tyr Asp Ser Ile Glu Met Thr Lys Lys Ala Glu Lys 85 90 95 atg ggc gtc gat gcg att ttg gca gtt gct ccg tat tat aac aaa cca 336 Met Gly Val Asp Ala Ile Leu Ala Val Ala Pro Tyr Tyr Asn Lys Pro 100 105 110 aac cag gaa gga tta tat caa cat ttt aag gca att gct gaa agt aca 384 Asn Gln Glu Gly Leu Tyr Gln His Phe Lys Ala Ile Ala Glu Ser Thr 115 120 125 tcc ctt cct gtt atc att tat aac att ccc gga aga tct gtt gtg aat 432 Ser Leu Pro Val Ile Ile Tyr Asn Ile Pro Gly Arg Ser Val Val Asn 130 135 140 atc gag cct gaa acg gtc atc cgt ttg tcc aag att ccg aac att gtt 480 Ile Glu Pro Glu Thr Val Ile Arg Leu Ser Lys Ile Pro Asn Ile Val 145 150 155 160 ggt atc aaa gaa gca ggc ggg aat ctt agt gcg atg acg caa att att 528 Gly Ile Lys Glu Ala Gly Gly Asn Leu Ser Ala Met Thr Gln Ile Ile 165 170 175 gcc aat aca gat gac gat ttt ctt ttg tat agc gga gac gac ggt tta 576 Ala Asn Thr Asp Asp Asp Phe Leu Leu Tyr Ser Gly Asp Asp Gly Leu 180 185 190 acc ttg cca gta ctg tcc att ggc gga acc ggg gtt att tct gtg gca 624 Thr Leu Pro Val Leu Ser Ile Gly Gly Thr Gly Val Ile Ser Val Ala 195 200 205 tcc cat gtt atc gga aat gaa atg caa gaa atg atc agt gca ttt tta 672 Ser His Val Ile Gly Asn Glu Met Gln Glu Met Ile Ser Ala Phe Leu 210 215 220 aat gga gat tat gaa cgt gcg gca aaa att cat caa aag ctg ctt ccg 720 Asn Gly Asp Tyr Glu Arg Ala Ala Lys Ile His Gln Lys Leu Leu Pro 225 230 235 240 ctt atg gat gga tta ttt atc gct cca aac cct gta ccg gtt aaa act 768 Leu Met Asp Gly Leu Phe Ile Ala Pro Asn Pro Val Pro Val Lys Thr 245 250 255 gct ttg caa att aaa ggc atg gat gtc ggt tcg gtt cgc ttg cct ctt 816 Ala Leu Gln Ile Lys Gly Met Asp Val Gly Ser Val Arg Leu Pro Leu 260 265 270 gtt ccg ctt act gaa caa gag cga aat aca gtg gca gca tta tta aat 864 Val Pro Leu Thr Glu Gln Glu Arg Asn Thr Val Ala Ala Leu Leu Asn 275 280 285 gct tta taa 873 Ala Leu 290 2 290 PRT Bacillus methanolicus 2 Met Val Ser Phe Gly Arg Ile Ser Thr Ala Met Val Thr Pro Phe Asp 1 5 10 15 Asn Lys Gly His Ile Asp Phe Ala Lys Thr Thr Gln Leu Val Asn His 20 25 30 Leu Ile Asn Asn Gly Ser Asp Ser Leu Val Val Val Gly Thr Thr Gly 35 40 45 Glu Ser Ala Thr Leu Thr Lys Glu Glu Lys Leu Ala Leu Phe Gln His 50 55 60 Val Val Lys Val Val Glu Lys Arg Val Pro Val Ile Ala Gly Thr Gly 65 70 75 80 Ser Asn Asn Thr Tyr Asp Ser Ile Glu Met Thr Lys Lys Ala Glu Lys 85 90 95 Met Gly Val Asp Ala Ile Leu Ala Val Ala Pro Tyr Tyr Asn Lys Pro 100 105 110 Asn Gln Glu Gly Leu Tyr Gln His Phe Lys Ala Ile Ala Glu Ser Thr 115 120 125 Ser Leu Pro Val Ile Ile Tyr Asn Ile Pro Gly Arg Ser Val Val Asn 130 135 140 Ile Glu Pro Glu Thr Val Ile Arg Leu Ser Lys Ile Pro Asn Ile Val 145 150 155 160 Gly Ile Lys Glu Ala Gly Gly Asn Leu Ser Ala Met Thr Gln Ile Ile 165 170 175 Ala Asn Thr Asp Asp Asp Phe Leu Leu Tyr Ser Gly Asp Asp Gly Leu 180 185 190 Thr Leu Pro Val Leu Ser Ile Gly Gly Thr Gly Val Ile Ser Val Ala 195 200 205 Ser His Val Ile Gly Asn Glu Met Gln Glu Met Ile Ser Ala Phe Leu 210 215 220 Asn Gly Asp Tyr Glu Arg Ala Ala Lys Ile His Gln Lys Leu Leu Pro 225 230 235 240 Leu Met Asp Gly Leu Phe Ile Ala Pro Asn Pro Val Pro Val Lys Thr 245 250 255 Ala Leu Gln Ile Lys Gly Met Asp Val Gly Ser Val Arg Leu Pro Leu 260 265 270 Val Pro Leu Thr Glu Gln Glu Arg Asn Thr Val Ala Ala Leu Leu Asn 275 280 285 Ala Leu 290 3 801 DNA Bacillus methanolicus CDS (1)..(798) 3 atg gaa att gta aaa att gtt gta gca ggc ccg cgc gga cga atg ggg 48 Met Glu Ile Val Lys Ile Val Val Ala Gly Pro Arg Gly Arg Met Gly 1 5 10 15 cgg gaa gca gtc cat ctt gtc ggg aga aca gaa aat ttc gag ttg gca 96 Arg Glu Ala Val His Leu Val Gly Arg Thr Glu Asn Phe Glu Leu Ala 20 25 30 gca gtg ctg gat aat aag aat gac gga aaa aat ctt tcc gaa ttg gaa 144 Ala Val Leu Asp Asn Lys Asn Asp Gly Lys Asn Leu Ser Glu Leu Glu 35 40 45 ggt ttt caa gga ttt gat gcc cct gtg tat aca aat att gaa aaa tgt 192 Gly Phe Gln Gly Phe Asp Ala Pro Val Tyr Thr Asn Ile Glu Lys Cys 50 55 60 ttt caa gat acc ggc gca gat gtc tta atc gat ttg acg act cct gaa 240 Phe Gln Asp Thr Gly Ala Asp Val Leu Ile Asp Leu Thr Thr Pro Glu 65 70 75 80 gta ggc tac tat cat aca aaa acg gct ctc gaa tat gga gtg cgg cct 288 Val Gly Tyr Tyr His Thr Lys Thr Ala Leu Glu Tyr Gly Val Arg Pro 85 90 95 gta gtt ggg acg acg ggt ttt acg aaa gat caa tta aaa gaa att gaa 336 Val Val Gly Thr Thr Gly Phe Thr Lys Asp Gln Leu Lys Glu Ile Glu 100 105 110 gaa att tgc gaa gaa aag aaa ctt ggc tgc att ata gcg cca aat ttt 384 Glu Ile Cys Glu Glu Lys Lys Leu Gly Cys Ile Ile Ala Pro Asn Phe 115 120 125 gcg gtt ggg gct gta tta atg atg aaa ttt tca caa atg gca gcc aag 432 Ala Val Gly Ala Val Leu Met Met Lys Phe Ser Gln Met Ala Ala Lys 130 135 140 tat ttt caa gat att gaa att att gaa ctg cat cat gat caa aaa ttg 480 Tyr Phe Gln Asp Ile Glu Ile Ile Glu Leu His His Asp Gln Lys Leu 145 150 155 160 gat gca ccg tcc gga aca gct gtc aaa aca gct gag atg att gcg gaa 528 Asp Ala Pro Ser Gly Thr Ala Val Lys Thr Ala Glu Met Ile Ala Glu 165 170 175 gtg aga gaa gca aag aag cag ggt cat cca aat gaa aaa gaa acg atc 576 Val Arg Glu Ala Lys Lys Gln Gly His Pro Asn Glu Lys Glu Thr Ile 180 185 190 atc ggt gca agg ggt gcg gat tat gaa gga atg cat att cat tct gtt 624 Ile Gly Ala Arg Gly Ala Asp Tyr Glu Gly Met His Ile His Ser Val 195 200 205 cgt ttg ccg gga tta att gcc cat cag cag gtg atg ttt gga tca gac 672 Arg Leu Pro Gly Leu Ile Ala His Gln Gln Val Met Phe Gly Ser Asp 210 215 220 ggg caa aca ttg acg atc cgc cac gat tcg tat aac cgg gca tct ttc 720 Gly Gln Thr Leu Thr Ile Arg His Asp Ser Tyr Asn Arg Ala Ser Phe 225 230 235 240 atg tct ggc gta aag cat gcc gtt gag acg gtt tta aaa att gat acg 768 Met Ser Gly Val Lys His Ala Val Glu Thr Val Leu Lys Ile Asp Thr 245 250 255 ttt gtt tac gga tta gaa aat att att gaa tag 801 Phe Val Tyr Gly Leu Glu Asn Ile Ile Glu 260 265 4 266 PRT Bacillus methanolicus 4 Met Glu Ile Val Lys Ile Val Val Ala Gly Pro Arg Gly Arg Met Gly 1 5 10 15 Arg Glu Ala Val His Leu Val Gly Arg Thr Glu Asn Phe Glu Leu Ala 20 25 30 Ala Val Leu Asp Asn Lys Asn Asp Gly Lys Asn Leu Ser Glu Leu Glu 35 40 45 Gly Phe Gln Gly Phe Asp Ala Pro Val Tyr Thr Asn Ile Glu Lys Cys 50 55 60 Phe Gln Asp Thr Gly Ala Asp Val Leu Ile Asp Leu Thr Thr Pro Glu 65 70 75 80 Val Gly Tyr Tyr His Thr Lys Thr Ala Leu Glu Tyr Gly Val Arg Pro 85 90 95 Val Val Gly Thr Thr Gly Phe Thr Lys Asp Gln Leu Lys Glu Ile Glu 100 105 110 Glu Ile Cys Glu Glu Lys Lys Leu Gly Cys Ile Ile Ala Pro Asn Phe 115 120 125 Ala Val Gly Ala Val Leu Met Met Lys Phe Ser Gln Met Ala Ala Lys 130 135 140 Tyr Phe Gln Asp Ile Glu Ile Ile Glu Leu His His Asp Gln Lys Leu 145 150 155 160 Asp Ala Pro Ser Gly Thr Ala Val Lys Thr Ala Glu Met Ile Ala Glu 165 170 175 Val Arg Glu Ala Lys Lys Gln Gly His Pro Asn Glu Lys Glu Thr Ile 180 185 190 Ile Gly Ala Arg Gly Ala Asp Tyr Glu Gly Met His Ile His Ser Val 195 200 205 Arg Leu Pro Gly Leu Ile Ala His Gln Gln Val Met Phe Gly Ser Asp 210 215 220 Gly Gln Thr Leu Thr Ile Arg His Asp Ser Tyr Asn Arg Ala Ser Phe 225 230 235 240 Met Ser Gly Val Lys His Ala Val Glu Thr Val Leu Lys Ile Asp Thr 245 250 255 Phe Val Tyr Gly Leu Glu Asn Ile Ile Glu 260 265
Claims (10)
1. A protein defined in the following (A) or (B):
(A) a protein which has the amino acid sequence of SEQ ID NO: 2 shown in Sequence Listing, or
(B) a protein which has an amino acid sequence of SEQ ID NO: 2 shown in Sequence Listing including substitution, deletion, insertion, addition or inversion of one or several amino acids, and has dihydrodipicolinate synthase activity.
2. A DNA which codes for a protein defined in the following (A) or (B):
(A) a protein which has the amino acid sequence of SEQ ID NO: 2 shown in Sequence Listing, or
(B) a protein which has an amino acid sequence of SEQ ID NO: 2 shown in Sequence Listing including substitution, deletion, insertion, addition or inversion of one or several amino acids, and has dihydrodipicolinate synthase activity.
3. The DNA according to claim 2 , which is a DNA defined in the following (a) or (b):
(a) a DNA which has a nucleotide sequence comprising at least the nucleotide sequence of the nucleotide numbers 1 to 924 in SEQ ID NO: 1 shown in Sequence Listing; or
(b) a DNA which is hybridizable with a nucleotide sequence comprising at least the nucleotide sequence of the nucleotide numbers 1 to 924 in SEQ ID NO: 1 shown in Sequence Listing under a stringent condition, and codes for a protein having dihydrodipicolinate synthase activity.
4. The DNA according to claim 3 , wherein the stringent condition is a condition in which washing is performed at 60° C., 1×SSC and 0.1% SDS.
5. A protein defined in the following (C) or (D):
(C) a protein which has the amino acid sequence of SEQ ID NO: 4 shown in Sequence Listing, or
(D) a protein which has an amino acid sequence of SEQ ID NO: 4 shown in Sequence Listing including substitution, deletion, insertion, addition or inversion of one or several amino acids, and has dihydrodipicolinate reductase activity.
6. A DNA which codes for a protein defined in the following (C) or (D):
(C) a protein which has the amino acid sequence of SEQ ID NO: 4 shown in Sequence Listing, or
(D) a protein which has an amino acid sequence of SEQ ID NO: 4 shown in Sequence Listing including substitution, deletion, insertion, addition or inversion of one or several amino acids, and has dihydrodipicolinate reductase activity.
7. The DNA according to claim 6 , which is a DNA defined in the following (c) or (d):
(c) a DNA which has a nucleotide sequence comprising at least the nucleotide sequence of the nucleotide numbers 1 to 798 in SEQ ID NO: 3 shown in Sequence Listing; or
(d) a DNA which is hybridizable with a nucleotide sequence comprising at least the nucleotide sequence of the nucleotide numbers 1 to 798 in SEQ ID NO: 3 shown in Sequence Listing under a stringent condition, and codes for a protein having dihydrodipicolinate reductase activity.
8. The DNA according to claim 7 , wherein the stringent condition is a condition in which washing is performed at 60° C., 1×SSC and 0.1% SDS.
9. A microorganism which is introduced with the DNA according to claim 2 or the DNA according to claim 6 or the both in a form that allows expression of a protein encoded by each DNA.
10. A method for producing L-lysine, which comprises culturing the microorganism according to claim 9 in a medium to produce and accumulate L-lysine in the medium, and collecting the L-lysine from the medium.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/214,556 US6878533B2 (en) | 1999-08-04 | 2002-08-09 | Gene encoding dihydrodipicolinate synthase from Bacillus methanolicus and methods of making lysine wing said gene |
| US11/073,741 US7211421B2 (en) | 1999-08-04 | 2005-03-08 | Gene encoding dihydrodipicolinate reductase from Bacillus methanolicus |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11221468A JP2001046067A (en) | 1999-08-04 | 1999-08-04 | L-lysine biosynthetic gene derived from thermophilic bacillus bacterium |
| JP11-221468 | 1999-08-04 | ||
| US09/631,828 US6461852B1 (en) | 1999-08-04 | 2000-08-03 | Dihydrodipicolinate synthase from Bacillus methanolicus |
| US10/214,556 US6878533B2 (en) | 1999-08-04 | 2002-08-09 | Gene encoding dihydrodipicolinate synthase from Bacillus methanolicus and methods of making lysine wing said gene |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/631,828 Division US6461852B1 (en) | 1999-08-04 | 2000-08-03 | Dihydrodipicolinate synthase from Bacillus methanolicus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/073,741 Division US7211421B2 (en) | 1999-08-04 | 2005-03-08 | Gene encoding dihydrodipicolinate reductase from Bacillus methanolicus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20030013174A1 true US20030013174A1 (en) | 2003-01-16 |
| US6878533B2 US6878533B2 (en) | 2005-04-12 |
Family
ID=16767196
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/631,828 Expired - Fee Related US6461852B1 (en) | 1999-08-04 | 2000-08-03 | Dihydrodipicolinate synthase from Bacillus methanolicus |
| US10/214,556 Expired - Lifetime US6878533B2 (en) | 1999-08-04 | 2002-08-09 | Gene encoding dihydrodipicolinate synthase from Bacillus methanolicus and methods of making lysine wing said gene |
| US11/073,741 Expired - Fee Related US7211421B2 (en) | 1999-08-04 | 2005-03-08 | Gene encoding dihydrodipicolinate reductase from Bacillus methanolicus |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/631,828 Expired - Fee Related US6461852B1 (en) | 1999-08-04 | 2000-08-03 | Dihydrodipicolinate synthase from Bacillus methanolicus |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/073,741 Expired - Fee Related US7211421B2 (en) | 1999-08-04 | 2005-03-08 | Gene encoding dihydrodipicolinate reductase from Bacillus methanolicus |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US6461852B1 (en) |
| EP (2) | EP1621624A1 (en) |
| JP (1) | JP2001046067A (en) |
| DE (1) | DE60024178T2 (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040142435A1 (en) * | 2002-11-20 | 2004-07-22 | Yoshiya Gunji | Method for producing L-amino acid using methylotroph |
| US20040166570A1 (en) * | 2003-02-10 | 2004-08-26 | Takayuki Asahara | Genes involved in polysaccharide production and utilization thereof |
| US20040171134A1 (en) * | 2003-01-08 | 2004-09-02 | Takayuki Asahara | Method for producing recombinant of methanol-assimilating bacterium |
| US20040191875A1 (en) * | 2003-03-04 | 2004-09-30 | Ryo Takeshita | Method for producing target substance |
| US20040197918A1 (en) * | 1999-08-12 | 2004-10-07 | Yumi Matsuzaki | Plasmid autonomously replicable in coryneform bacteria |
| US20040214296A1 (en) * | 2003-01-29 | 2004-10-28 | Takayuki Asahara | Method for producing L-lysine using methanol-utilizing bacterium |
| US20040229311A1 (en) * | 2003-02-25 | 2004-11-18 | Seiko Hirano | Novel lysine decarboxylase gene and method for producing L-lysine |
| US20050003495A1 (en) * | 2002-11-20 | 2005-01-06 | Yoshiya Gunji | Method for producing L-lysine or L-arginine by using methanol-assimilating bacterium |
| US20050176121A1 (en) * | 2001-09-06 | 2005-08-11 | Ryo Takeshita | Method for producing alcohol by using microorganism |
| US20050233416A1 (en) * | 1999-08-04 | 2005-10-20 | Nobuharu Tsujimoto | Lysine biosynthetic system genes derived from thermophilic bacteria |
| US20060040365A1 (en) * | 2004-08-10 | 2006-02-23 | Kozlov Yury I | Use of phosphoketolase for producing useful metabolites |
| EP2262894A4 (en) * | 2008-03-03 | 2012-07-04 | Global Bio Chem Technology Group Company Ltd | RECOMBINANT MICROORGANISM AND PROCESS FOR PRODUCTION OF L-LYSINE |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60232120D1 (en) * | 2001-06-12 | 2009-06-10 | Ajinomoto Kk | Process for the preparation of L-lysine or L-arginine using methanolassimilating bacteria |
| US6911332B2 (en) | 2002-06-12 | 2005-06-28 | Ajinomoto Co., Inc. | Isolated polynucleotides encoding d-arabino-3-hexulose-6-phosphate synthases from Methylophilus methylotrophus |
| US7026149B2 (en) * | 2003-02-28 | 2006-04-11 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in the stress response to environmental changes in Methylophilus methylotrophus |
| US7029893B2 (en) * | 2003-02-28 | 2006-04-18 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in amino acid biosynthesis in methylophilus methylotrophus |
| US7060475B2 (en) * | 2003-02-28 | 2006-06-13 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in intermediates metabolism of central metabolic pathway in methylophilus methylotrophus |
| US7468262B2 (en) * | 2003-05-16 | 2008-12-23 | Ajinomoto Co., Inc. | Polynucleotides encoding useful polypeptides in corynebacterium glutamicum ssp. lactofermentum |
| US20050255568A1 (en) * | 2003-05-30 | 2005-11-17 | Bailey Richard B | Methods and compositions for amino acid production |
| CN103088080B (en) | 2004-10-07 | 2016-02-17 | 味之素株式会社 | Method for producing alkaline substances |
| JP2007185184A (en) * | 2005-12-16 | 2007-07-26 | Ajinomoto Co Inc | L-amino acid-productive microorganism and method for producing l-amino acid |
| CN101374953B (en) | 2006-01-27 | 2011-09-28 | 味之素株式会社 | Method for producing l-amino acid |
| WO2007086618A1 (en) | 2006-01-30 | 2007-08-02 | Ajinomoto Co., Inc. | L-amino acid producing bacterium and method of producing l-amino acid |
| JP2009089603A (en) * | 2006-02-02 | 2009-04-30 | Ajinomoto Co Inc | Method for producing l-lysine using methanol-assimilating bacterium |
| BRPI0703692B1 (en) * | 2006-12-25 | 2016-12-27 | Ajinomoto Kk | A method for obtaining the crystals of a basic amino acid hydrochloride comprising generating a basic amino acid using microbial cells by fermentation in a fermentation broth or by an enzymatic method in an enzyme reaction solution using the cells as catalysts. |
| JP2010088301A (en) * | 2007-02-01 | 2010-04-22 | Ajinomoto Co Inc | Method for production of l-amino acid |
| JP2010130899A (en) | 2007-03-14 | 2010-06-17 | Ajinomoto Co Inc | Microorganism producing l-glutamic acid-based amino acid, and method for producing amino acid |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4346170A (en) * | 1979-07-23 | 1982-08-24 | Ajinomoto Company, Incorporated | Method for producing L-lysine by fermentation |
| US5426052A (en) * | 1989-04-10 | 1995-06-20 | Regents Of The University Of Minnesota | Bacillus MGA3 diaminopimelate decarboxylase gene |
| US6110713A (en) * | 1993-03-23 | 2000-08-29 | Regents Of The University Of Minnesota | Production of glutamic acid and lysine using auxotrophic mutants of Bacillus methanolicus |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04160257A (en) | 1990-10-25 | 1992-06-03 | Sumitomo Heavy Ind Ltd | Inscribed engagement planetary gear structure |
| BR9606379A (en) | 1995-06-07 | 1997-08-12 | Ajinomoto Kk | Recombinant DNA replicable in cells of corinform bacteria corineform bacteria process to produce l-lysine |
| AU1091999A (en) * | 1997-10-17 | 1999-05-10 | Regents Of The University Of Minnesota | Production of lysine using salt tolerant, methanol utilizing bacillus |
| JP2001046067A (en) * | 1999-08-04 | 2001-02-20 | Ajinomoto Co Inc | L-lysine biosynthetic gene derived from thermophilic bacillus bacterium |
| PL341895A1 (en) * | 1999-08-12 | 2001-02-26 | Ajinomoto Kk | Plasmide autonomously replicable in corynebacter bacteria |
| JP2001120292A (en) * | 1999-08-17 | 2001-05-08 | Ajinomoto Co Inc | Method for producing l-amino acid by fermentation method |
| JP2001120269A (en) * | 1999-10-22 | 2001-05-08 | Ajinomoto Co Inc | Method for producing l-lysine by method for fermentation |
| JP4380029B2 (en) * | 2000-07-05 | 2009-12-09 | 味の素株式会社 | Manufacturing method of substances using microorganisms |
| EP1217076B1 (en) * | 2000-12-22 | 2006-06-14 | Ajinomoto Co., Inc. | Method of producing a target substance by fermentation |
| JP2002330763A (en) * | 2001-05-02 | 2002-11-19 | Ajinomoto Co Inc | Method for producing objective substance by fermentation |
| DE60232120D1 (en) * | 2001-06-12 | 2009-06-10 | Ajinomoto Kk | Process for the preparation of L-lysine or L-arginine using methanolassimilating bacteria |
| US6911332B2 (en) * | 2002-06-12 | 2005-06-28 | Ajinomoto Co., Inc. | Isolated polynucleotides encoding d-arabino-3-hexulose-6-phosphate synthases from Methylophilus methylotrophus |
| JP2004166595A (en) * | 2002-11-20 | 2004-06-17 | Ajinomoto Co Inc | Method for producing l-amino acid by using methylotroph |
| JP4120364B2 (en) * | 2002-11-20 | 2008-07-16 | 味の素株式会社 | Method for producing L-lysine or L-arginine using methanol-assimilating bacteria |
| JP2004166592A (en) * | 2002-11-20 | 2004-06-17 | Ajinomoto Co Inc | Method for producing l-amino acid using methylotroph |
| US20040171134A1 (en) * | 2003-01-08 | 2004-09-02 | Takayuki Asahara | Method for producing recombinant of methanol-assimilating bacterium |
| DE102004001674B4 (en) * | 2003-01-29 | 2019-01-24 | Ajinomoto Co., Inc. | Process for the preparation of L-lysine using methanol-utilizing bacteria |
| JP2004236637A (en) * | 2003-02-10 | 2004-08-26 | Ajinomoto Co Inc | Gene associated with polysaccharide production and use of the same |
| JP2004254544A (en) * | 2003-02-25 | 2004-09-16 | Ajinomoto Co Inc | New lysine decaroboxylase gene and method for producing l-lysine |
| US7060475B2 (en) * | 2003-02-28 | 2006-06-13 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in intermediates metabolism of central metabolic pathway in methylophilus methylotrophus |
| US7029893B2 (en) * | 2003-02-28 | 2006-04-18 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in amino acid biosynthesis in methylophilus methylotrophus |
| US7026149B2 (en) * | 2003-02-28 | 2006-04-11 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in the stress response to environmental changes in Methylophilus methylotrophus |
| JP2004261150A (en) * | 2003-03-04 | 2004-09-24 | Ajinomoto Co Inc | Method for producing objective material |
| US7468262B2 (en) * | 2003-05-16 | 2008-12-23 | Ajinomoto Co., Inc. | Polynucleotides encoding useful polypeptides in corynebacterium glutamicum ssp. lactofermentum |
| KR100928382B1 (en) | 2006-10-17 | 2009-11-23 | 삼성에스디에스 주식회사 | Migration apparatus which convert database of mainframe system into database of open system and method for thereof |
-
1999
- 1999-08-04 JP JP11221468A patent/JP2001046067A/en active Pending
-
2000
- 2000-08-01 EP EP05017544A patent/EP1621624A1/en not_active Withdrawn
- 2000-08-01 EP EP00116623A patent/EP1074626B9/en not_active Expired - Lifetime
- 2000-08-01 DE DE60024178T patent/DE60024178T2/en not_active Expired - Lifetime
- 2000-08-03 US US09/631,828 patent/US6461852B1/en not_active Expired - Fee Related
-
2002
- 2002-08-09 US US10/214,556 patent/US6878533B2/en not_active Expired - Lifetime
-
2005
- 2005-03-08 US US11/073,741 patent/US7211421B2/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4346170A (en) * | 1979-07-23 | 1982-08-24 | Ajinomoto Company, Incorporated | Method for producing L-lysine by fermentation |
| US5426052A (en) * | 1989-04-10 | 1995-06-20 | Regents Of The University Of Minnesota | Bacillus MGA3 diaminopimelate decarboxylase gene |
| US6110713A (en) * | 1993-03-23 | 2000-08-29 | Regents Of The University Of Minnesota | Production of glutamic acid and lysine using auxotrophic mutants of Bacillus methanolicus |
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7211421B2 (en) | 1999-08-04 | 2007-05-01 | Ajinomoto Co., Inc. | Gene encoding dihydrodipicolinate reductase from Bacillus methanolicus |
| US20050233416A1 (en) * | 1999-08-04 | 2005-10-20 | Nobuharu Tsujimoto | Lysine biosynthetic system genes derived from thermophilic bacteria |
| US7244569B2 (en) | 1999-08-12 | 2007-07-17 | Ajinomoto Co., Inc. | Plasmid autonomously replicable in coryneform bacteria |
| US20040197918A1 (en) * | 1999-08-12 | 2004-10-07 | Yumi Matsuzaki | Plasmid autonomously replicable in coryneform bacteria |
| US20050176121A1 (en) * | 2001-09-06 | 2005-08-11 | Ryo Takeshita | Method for producing alcohol by using microorganism |
| US7335506B2 (en) | 2002-11-20 | 2008-02-26 | Ajinomoto Co., Inc. | Method for producing L-lysine or L-arginine by using methanol-assimilating bacterium |
| US20040142435A1 (en) * | 2002-11-20 | 2004-07-22 | Yoshiya Gunji | Method for producing L-amino acid using methylotroph |
| US7217543B2 (en) | 2002-11-20 | 2007-05-15 | Ajinomoto Co., Inc. | Method for producing L-amino acid using methylotroph |
| US20050003495A1 (en) * | 2002-11-20 | 2005-01-06 | Yoshiya Gunji | Method for producing L-lysine or L-arginine by using methanol-assimilating bacterium |
| US20040171134A1 (en) * | 2003-01-08 | 2004-09-02 | Takayuki Asahara | Method for producing recombinant of methanol-assimilating bacterium |
| US20040214296A1 (en) * | 2003-01-29 | 2004-10-28 | Takayuki Asahara | Method for producing L-lysine using methanol-utilizing bacterium |
| US7211416B2 (en) | 2003-01-29 | 2007-05-01 | Ajinomoto Co., Inc. | Method for producing L-lysine using methanol-utilizing bacterium |
| US20040166570A1 (en) * | 2003-02-10 | 2004-08-26 | Takayuki Asahara | Genes involved in polysaccharide production and utilization thereof |
| US20040229311A1 (en) * | 2003-02-25 | 2004-11-18 | Seiko Hirano | Novel lysine decarboxylase gene and method for producing L-lysine |
| US7160704B2 (en) | 2003-03-04 | 2007-01-09 | Ajinomoto Co., Inc. | Method for producing target substance |
| US20040191875A1 (en) * | 2003-03-04 | 2004-09-30 | Ryo Takeshita | Method for producing target substance |
| US20060040365A1 (en) * | 2004-08-10 | 2006-02-23 | Kozlov Yury I | Use of phosphoketolase for producing useful metabolites |
| US7785858B2 (en) | 2004-08-10 | 2010-08-31 | Ajinomoto Co., Inc. | Use of phosphoketolase for producing useful metabolites |
| US20100267094A1 (en) * | 2004-08-10 | 2010-10-21 | Yury Ivanovich Kozlov | Use of phosphoketolase for producing useful metabolites |
| US8404474B2 (en) | 2004-08-10 | 2013-03-26 | Ajinomoto Co., Inc. | Use of phosphoketolase for producing useful metabolites |
| US8753849B2 (en) | 2004-08-10 | 2014-06-17 | Ajinomoto Co., Inc. | Use of phosphoketolase for producing useful metabolites |
| US8969048B2 (en) | 2004-08-10 | 2015-03-03 | Ajinomoto Co., Inc. | Use of phosphoketolase for producing useful metabolites |
| EP2262894A4 (en) * | 2008-03-03 | 2012-07-04 | Global Bio Chem Technology Group Company Ltd | RECOMBINANT MICROORGANISM AND PROCESS FOR PRODUCTION OF L-LYSINE |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1074626B1 (en) | 2005-11-23 |
| US6878533B2 (en) | 2005-04-12 |
| EP1074626A2 (en) | 2001-02-07 |
| US7211421B2 (en) | 2007-05-01 |
| US20050233416A1 (en) | 2005-10-20 |
| DE60024178T2 (en) | 2006-08-10 |
| EP1621624A1 (en) | 2006-02-01 |
| EP1074626B9 (en) | 2006-07-19 |
| DE60024178D1 (en) | 2005-12-29 |
| JP2001046067A (en) | 2001-02-20 |
| US6461852B1 (en) | 2002-10-08 |
| EP1074626A3 (en) | 2002-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6461852B1 (en) | Dihydrodipicolinate synthase from Bacillus methanolicus | |
| JP3783065B2 (en) | Method for producing L-lysine | |
| CN111315876B (en) | ATP phosphoribosyltransferase mutant and method for producing L-histidine using same | |
| US8017362B2 (en) | Method for producing L-methionine by fermentation | |
| KR100268324B1 (en) | Method of Making L-Lysine | |
| EP1253195B1 (en) | Process for producing l-lysine | |
| EP0811682B2 (en) | Method of producing L-lysine | |
| JP4075087B2 (en) | Method for producing L-lysine | |
| KR100420743B1 (en) | Methods for the preparation of novel lysine decarboxylase genes and L-lysine | |
| JP4168463B2 (en) | Method for producing L-lysine | |
| EP1172437A1 (en) | Novel desensitized aspartokinase | |
| EP0854189A2 (en) | Method for producing L-lysine | |
| JPWO1995023864A1 (en) | Method for producing L-lysine | |
| CZ327297A3 (en) | Coded dna for aspartokinase and process for preparing l-amino acid | |
| US20150037850A1 (en) | Recombinant microorganism producing quinolinic acid and a method for producing quinolinic acid using the same | |
| KR102246288B1 (en) | Microorganisms for producing putrescine and process for producing putrescine using them | |
| DK2430152T3 (en) | A microorganism with increased L-lysine productivity and method for producing L-lysine using the same | |
| KR20020042703A (en) | Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant Coryneform bacterium | |
| KR102267931B1 (en) | Novel 5-(carboxyamino)imidazole ribonucleotide synthase variant and a method for producing IMP using the same | |
| US7732176B2 (en) | Nucleotide sequences that encode deregulated phosphoglycerate dehydrogenases of coryneform bacteria and method for producing L-serine | |
| US7033802B1 (en) | Penicillin binding protein gene and process for producing L-glutamic acid | |
| KR20250158598A (en) | Variant of protein and a method for producing L-Threonine using the same | |
| JPWO1999045131A1 (en) | Penicillin-binding protein gene and method for producing L-glutamic acid | |
| ZA200204973B (en) | Process for producing L-Lysine. | |
| JP2004242564A (en) | Vector of bacterium of genus methylophilus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FEPP | Fee payment procedure |
Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| CC | Certificate of correction | ||
| FPAY | Fee payment |
Year of fee payment: 4 |
|
| FPAY | Fee payment |
Year of fee payment: 8 |
|
| FPAY | Fee payment |
Year of fee payment: 12 |